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ABSTRACT 
MicroRNAs (miRNAs) are small non-coding RNAs that negatively regulate gene 
expression at the post-transcriptional level. They exert diverse functions in 
controlling normal tissue and organ development and physiology. Many 
miRNAs show spatially and temporally restricted expression patterns during 
vertebrate eye development but the roles of individual miRNAs in controlling this 
process remain  however, largely unknown. The aim of my thesis was to shed 
further light on the role of specific miRNAs in regulating basic processes of 
ocular development mainly by exploiting the medakafish (Oryzias latipes) model 
system. In particular, I focused my attention on the miRNA subfamily constituted 
by miR-181a and miR-181b, which are expressed in the Inner Nuclear Layer 
(INL) and Ganglion Cell Layer (GCL) of the vertebrate retina. Morpholino-
mediated combined knockdown of miR-181a/b function in medakafish results in 
a specific retinal phenotype characterized by the reduction of Inner Plexiform 
Layer (IPL) thickness, without any apparent reduction in the number of retinal 
cells. To dissect this phenotype further, I studied the consequences of miR-
181a/b ablation in two medakafish transgenic lines, namely GFP-Six3.2 and 
GFP-Ath5, in which GFP expression can be specifically visualized in amacrine 
and retinal ganglion cells (RGCs), respectively.  This analysis revealed that 
miR-181a/b exert a role in the specification and growth of amacrine and RGC 
axons. The above alterations translate into an impairment of retinal circuits 
assembly and to visual function defects, as assessed by the evaluation of the 
Optokinetic Response (OKR) behavioral test. Using a combination of 
bioinformatic, as well as on in vitro and in vivo experimental approaches, I 
identified ERK2, a kinase member of the MAPK signaling cascade, as one of 
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the direct targets of these two microRNAs. I demonstrated that the function of 
miR-181a/b in growth cone cytoskeleton remodeling during retinal development 
are largely mediated by ERK2 targeting and by the modulation of its 
downstream signaling cascade. Moreover I provide, for the first time, in vivo
evidence of an antagonism between the TGF- pathway and the ERK2 cascade 
in the regulation of retinal axon specification and growth, which is exerted via 
TGF- regulation of miR-181a/b levels. These data expand our knowledge on 
the role of miRNAs in eye patterning in vertebrates, and demonstrate that miR-
181a/b-targeting of ERK2 and the consequent modulation of the MAPK 
cascade, in concert with TGF--action, play important roles in the signaling 
network that define the correct wiring and  assembly of functional retina neural 
circuits. 

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1.INTRODUCTION
1.1 The vertebrate eye development 
The eye is a bilateral organ, part of the central nervous system, deputed to the 
visual perception of the surroundings. The complexity of this organ is reached 
through a series of inductive and morphogenetic events, coordinated by specific 
genetic programs, which are conserved among different vertebrate species (Fig. 
1 A-C). 
The eye originates at late gastrula stages with the specification of retinal 
precursors cells within the eye field in the anterior neural plate.  During 
neurulation, eye progenitor cells converge medially and are surrounded rostrally 
and laterally by telencephalic precursors and caudally and medially by cells that 
will form the diencephalon. The first morphological sign of eye development in 
vertebrates is the bilateral evagination of anterior diencephalon in the early 
neurula (Fig. 1 A, D, D’). Continued evagination of the optic primordial leads to 
the formation of the optic vesicles connected to the diencephalon by a small 
canal, the optic stalk. The optic vescicle extend towards the overlying, non-
neural surface ectoderm that will ultimately give rise to the lens and cornea. At 
this stage, the presumptive lens also shows the first morphological signs of 
development. This is characterized by formation of the lens placode, a 
thickening of the surface ectoderm that comes into contact with the optic vesicle 
(Chow and Lang, 2001) (Fig. 1 E’). Coordinated invagination of the lens placode 
and the optic vesicle results in the formation of the lens vesicle and a double-
layered optic cup and provides the first indication of the final shape of the eye 
(Fig. 1 C, F, F’) . The inner layer of the optic cup (facing the lens) forms the 
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neural retina (NR), while the outer layer of the optic cup gives rise to the retinal 
pigment epithelium (RPE) which will be formed of a single layer of cells 
containing melanin. The proximal ventral region will instead originate the optic 
fissure, from which the optic nerve derives. This structure provides a channel for 
blood vessels within the eye and it allows the egression of retinal axons from 
the eye cup.  The transition zone between the future retina and the RPE forms 
the Ciliary Margin (CM), or periphery of the retina (Fig. 1 F’). The Ciliary Margin 
differentiates into non neural structures: the proximal part into the ciliary 
epithelium while the distal part becomes the iris (Beebe, 1986). 
In vertebrates, the morphogenetic movements and the tissue interaction are 
orchestrated by specific genetic programs regulated by the interplay between a 
reduced number of signaling pathways and transcription factors. Information, in 
the form of signaling molecules derived also from the surrounding tissues, 
modulate and restrict the expression of different transcription factors driving the 
differentiation towards a specific cell type.  
In the optic cup formation, extracellular signals, derived from the surface 
ectoderm in contact with the prospective NR or from the periocular 
mesenchyme surrounding the presumptive RPE, pattern the distal optic vesicle. 
The surface ectoderm secretes high levels of two members of Fibroblast 
Growth Factor (FGF) signaling molecules family, FGF1 and FGF2, (Nguyen and 
Arnheiter, 2000) while members of the Transforming Growth Factor- (TGF-) 
signaling molecules superfamily, such as activins or the related Bone 
Morphogenetic Proteins (Bmp) - Bmp4 and Bmp7 - are expressed in the 
surrounding mesenchyme and/or the presumptive RPE itself (Fuhrmann et al., 
2000) (Fig. 1A). FGF and TGF-/BMP signaling act antagonistically on the 
specification of RPE and NR precursors. The first activates NR specification but 
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inhibits RPE formation by activation of the mitogen-activated protein kinase 
(MAPK) cascade which, in turn, promote the expression of Ceh10 
homeodomain-contain homolog (Chx10), that impose a NR character to the 
native optic vesicle cells, and reduce the expression of Orthodenticle homeobox 
2 (Otx2) and Microphtalmia transcriptor-associated factor (MITF), transcription 
factors crucial for the RPE identity. In contrast the induction of TGF-/BMP 
signaling by extraocular mesenchyme is essential for turning on the expression 
of RPE molecular markers such as MITF, and has an inhibitory effect on the 
expression of Chx10. Besides those mentioned above, a number of additional 
transcription factors are also specifically expressed in the presumptive neural 
retina and RPE. Currently, it is not clear how many of them are really needed to 
impose tissue specificity.  
Figure 1. Schematic overview of vertebrate eye development. 
(A, B, C) Distribution of inductive signals and transcription
the eye. Progressive tissue specification during th
optic vesicle (B) and optic cup (C) where the diffe
TGF-like signals from the extraocular mesenchyme promot
whereas FGF signals from the lens placode repress R
(light green in B). During optic cup for
in the ventral side establish the dorso
Shh: Sonic hedgehog; FGFs: Fibroblast grow factors;
(D, E, F) Schematic representation of initial eye morphogenesis.
as a protrusion of the anterior neural tube. E) Fol
generates the optic cup and the optic fissure. F) T
forms. D’). The optic vesicle neuroepithelium is co
and molecularly indistinguishable. E’) As the vesic
as presumptive RPE (dark green), the dist
while the ventral portion in optic stalk (light yel
lens placode (blue). F’) Complete folding of the ve
completely surround the neural retina. Abbreviations: L: l
mesenchyme; NR: neural retina; OS: optic stalk; OV:
epithelium; SE: surface ectoderm.
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Once established  the RPE and  NR identities, the retina differentiation process 
will give rise to an adult mature retina deputed to the transduction of visual 
stimuli to higher brain centers. The retina comprises seven major classes of 
cells, six of which are neurons (Wassle, 2004) whose cell bodies and 
connections are arranged in layers (Fig. 2 A). This laminar organization is 
stereotypic across species. The connections are restricted to two laminae: the 
outer plexiform layer (OPL) and the inner plexiform layer (IPL). Rod and cone 
photoreceptors in the outer nuclear layer (ONL) convert the light information into 
chemical and electrical signals that are relayed to interneurons. Bipolar 
interneurons in the inner nuclear layer (INL) are contacted by photoreceptors, in 
the OPL, and convey signals from the outer retina to the inner retina. The INL 
also comprises horizontal cells, which modulate the electric signal transmission, 
and Muller glial cells, which provide important structural and functional support 
in the maturation of retinal neurons and their connectivity. The bipolar cells form 
chemical synapses in the IPL with their targets, namely retinal ganglion cells 
(RGCs) and amacrine interneurons. Amacrine cells modulate the visual signals 
by regulating the release of neurotransmitters from the bipolar cells and 
providing inhibition directly onto ganglion cells. Light information leaves the 
retina via axons of the retinal ganglion cells that collectively form the optic 
nerve. 
Generation of the appropriate cell types, their numbers and distribution derive 
from cell-intrinsic (genetic) and extrinsic (environmental) signals that act in 
concert to specify cell fate. Decisions to become one or another type of retinal 
cell appear to depend on many factors, including the time of cell genesis. 
The seven types of cells differentiate from common progenitors in a temporal 
order widely conserved during evolution from fish to mammals: ganglion cells 
first, followed by horizontal cells
cells and Müller glial cells last 
Dawson and LaVail, 1979; Cepko et al., 1996; Hu and
al., 1991; Stiemke and Hollyfield, 1995; Young, 198
Figure 2. Schematic structure of the neural retina and its 
A) Vertebrate neural retina composed of seven types of
cellular layers. GCL, ganglion cell layer; INL, inn
and cone photoreceptors 
chemical and electrical signals that are relayed to
nuclear layer (INL) are contacted by photoreceptors
convey signals from the outer retina t
which modulate the electric signal transmission, an
structural and functional support. The bipolar 
the visual signals, and retinal ganglion cells (RGCs)
information leaves the retina via axons of the reti
optic nerve. B) Retinal cells are differentiated in an order cons
ganglion cells first and Müller glial cells last. 
According to the model of "competence", the differe
from a single common progenitor which change competency 
the control of extrinsic (such as neurotrophic fact
(such as transcription factors) 
Belliveau et al., 2000; Harris, 1997; Holt et al., 
Marquardt and Gruss, 2002; Turner and Cepko, 1987; 
this model, progenitors pass through intrinsically determined com
states, during which they are capable of giving ris
types under the influence of extrinsic signals 
10 
, cones and amacrine cells, 
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et al., 1997; Furukawa et al., 2000; Guillemot and Cepko, 1992; Kelley et al., 
1994; Zhang and Yang, 2001).  
TGF, EGF (epidermal growth factor) and ILF (leukemia inhibitor factor) are just 
some examples of extrinsic factors that can stimulate the production of specific 
retinal cells types, while leading to suppression of other (Lillien and Wancio, 
1998). Indeed genes coding for transcription factors of the family b-helix-loop-
helix, such as Ath5, mash1, NeuroD, or homeobox genes such as Otx2, Chx10, 
Pax6, Six3 and Crx act as intrinsic regulators (Bramblett et al., 2004; Brown et 
al., 2001; Burmeister et al., 1996; Dyer et al., 2003; Inoue et al., 2002; Li et al., 
2004; Marquardt et al., 2001; Mathers et al., 1997; Morrow et al., 1999; Satow 
et al., 2001; Tomita et al., 2000). These genes are important both for 
differentiation and maintenance of retinal cell types; in fact many of them are 
expressed at high levels in specific cellular regions also when the retina is 
completely differentiated.  Overall, the development of the eye is a highly 
complex  process, and the sequential and coordinated expression of numerous 
genes encoding for transcription factors, cofactors, signal transduction 
molecules, membrane receptors and others, more or less well characterized, 
play a key role in different stages of eye development and may be responsible, 
when mutated, for different eye malformations. 
1.2 The wiring in the retina 
Vision, of course, relies on the proper development of the retina. Following the 
generation of each cell type, the major developmental events in the retina 
regard the formation and maintenance of connections between its cellular 
components and between the retina and its brain targets. 
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Organization of the retina network occurs progressively and with precision. 
Accurate processing of visual information requires that the axons and dendrites 
target their synaptic partners, and that they form the appropriate balance of 
excitatory and inhibitory connections. For this reason, the various cell types 
need to express, for intercellular communication, their appropriate 
neurotransmitters, which together  with neurotrophic molecules play essential 
roles in the establishment of proper retina neural circuits. 
The structural development of retinal neuron arbors starts establishing cellular 
polarity and compartmentalization of neurites into the axons and dendrites. After 
becoming specified neurons, the cells begin to elaborate neurites. Usually 
during the polarization process, neurons typically estabilish a single process as 
axon and the remainder, or the subsequent, processes become dendrites 
(Horton and Ehlers, 2003). Since the initial event in establishing a polarized 
neuron is the determination of a single axon, the process was termed “axon 
specification” (Fukata et al., 2002). During axon specification, one of several 
seemingly identical nascent neurites undergoes drastic changes in its 
cytoskeletal and membrane composition, resulting in a neuritic process 
morphologically and functionally distinct from those that grow and develop into 
dendrites (Dotti and Banker, 1987; Goslin and Banker, 1989).  
Although molecular pathways that regulate neuronal polarity in other neural 
system have been already defined (Wozard 2002, Shi 2004, Jiang 2005, 
Yoshimura 2005), our knowledge of the factors that specifically stimulate axonal 
or dendritic outgrowth in retinal neurons is only just beginning to deepen. 
Morphological analyses revealed that retinal ganglion cells (RGCs) extend a 
single axonal process prior to elaborating dendrites (Hinds and Hinds, 1974; 
Maslim et al, 1986). In 2002, Goldberg et colleagues, demonstrated that purified 
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rat RGCs display an age-related bias in the rate of growth of axonal versus 
dendritic processes. Their data suggest the presence of an extrinsic contact-
mediated signal responsible for shifting ganglion cell outgrowth from an axon to 
a dendritic mode. This signal does not come from the axonal target zone but 
instead from direct contact with amacrine cells within the retina. Other works 
demonstrated that the development of RGC dendrites is not only regulated by 
intraretinal signaling but also by neuronal interaction in the brain  (Lom and 
Cohen-Cory, 1999; Lom et al 2002). The Brain-Derived Neurotrophic Factor 
(BDNF) is endogenously released in the retina as well as in the tectum where 
RGC axons make synapses. Increasing BDNF levels in the tectum result in 
more complex RGC dendritic and axonal arborizations, whereas increasing 
retinal BDNF has opposite effects on dendrites and no effects on axonal 
complexity, revealing that the effect of individual molecules is dependent also 
on the site of action. 
The RGC arborize in a laminar fashion in the inner plexiform layer (IPL), 
sometimes occupying single strata within a multilayered array of concentric 
circuits. In most species, five prominent sublaminae are identifiable in the IPL, 
termed S1 to S5 (Cajal, 1972). This sublaminae can be divided in the so called 
ON-region (S3 to S5) and OFF- region (S1 and S2) (Fig. 3). The ON 
(increments in light intensity) and OFF (decrements in light intensity) stimuli are 
processed in two vertical pathways and together provide contrast information 
that are elaborated by specialized circuits in the IPL, and then transmitted 
through the RGCs to the brain. Initially, it was considered that the ON-pathway 
cells restrict their arbors to the inner portion of the IPL (the ON region S3-S5), 
and the OFF-pathway cells occupy the outer region (the OFF region S1,S2) 
(Famiglietti and Kolb, 1976; Famiglietti et al 1977; Stell et al, 1977; Nelson et al 
1978). Later, it was demonstrated that ON
both regions (Ammermuller and Kolb, 1995).
Figure 3. Schematic representation of the Plexiform Layer str
Neuronal arbors stratify within the Inner Plexiform
position. On a gross level, the IPL is split in the
circuitry. Beyond this, the IPL can be divided into finer
Individual retinal circuits are constituted of conn
amacrine and ganglion cells, whose arbors co
A: Amacrine cells; RB: Rod
Horizontal cells; R: Rod; C: Cone; OPL: Outer Plexi
(Adapted from Morgan and Wong
Laminated circuits could arise via s
a) Sequential layering
preceding networks
b) Remodeling:
inappropriate regio
c) Targeting:
encountering localized molecular guidance signal
d) Contact-dependent guidance signal
e) Hierarchical:
or efferent target fileds.
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The current hypothesis is that the majority of mammalian RGCs progress from 
an early non-stratified stage - characterised by ON-OFF responses and 
ramification throughout the depth of the IPL - to a mature stratified stage 
whereupon they respond as strictly ON or OFF cells and dendritic arbors are 
restricted to corresponding regions of IPL (Bodnarenko et al, 1995, 1999; 
Lohmann and Wong 2001; Stacy and Wong 2003). Extensive reorganization, 
including the retraction of inappropriately placed dendrites, is suggested to lead 
to their mature stratification pattern (Chalupa and Gunhan, 2004; Maslim and 
Stone, 1988) (Fig. 4 B).
Cellular ablation studies have provided insights into the understanding of what 
cellular interrelationships are required to form stratified arborization in the IPL. 
In a Zebrafish mutant, in which RGCs never develop (lakritz), the bistratification 
pattern of a transgenically defined amacrine cell subpopulation was found to be 
nearly normal at maturity, showing only circumscribed areas of disruption (Kay 
et al 2004).  
Figure 4. A) Non-exclusive strategies for the formation of laminar c
layering; initial neurons elaborate stratified arbo
establish strata above or below 
throughout the neuropil initially, subsequent elimi
results in stratified patterns at maturity. (c) Tar
guidance cues arranged in laminar fashion such that
specific sublaminae. (d) Targeted (cellular); neuro
presented by guidepost cells and/or synaptic partne
to specific sublaminae. (e) Hierachical; neurons or
fashion such that resolving the axonal target field
vice versa. (a-e) Dashed box indicates 
from immature to mature st
ganglion cells (RGCs). (Adapte
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Despite the detailed studies on the development of RGC morphology, 
comparatively little is known about factors that shape the arborization of retinal 
interneurons,  amacrine and bipolar cells. However, these data demonstrate 
that the development of stratified arbor morphologies of bipolar and amacrine 
cells does not appear to depend on the presence of RGC dendrites. In addition, 
it has been shown that cholinergic amacrine cells stratify prior to most RGCs 
and bipolar cells, supporting the idea that some amacrine cells subtype may be 
positioned upstream, in a hierarchical sense, providing lamination cues for 
bipolar and RGC subtypes that then ramify in the sublaminae that they establish 
(Reese at al. 2001).  
However, very little information is still available about the molecular signals that 
regulate amacrine axon specification and stratification patterns. Evidence for 
general repulsive and/or attractive cues is lacking. The current model proposes 
that the distance between retinal synaptic partners is small enough that contact 
may result from polarized outgrowth alone without the need for positional 
gradients. 
To gain insight into the developmental rules that govern amacrine cell 
stratification and monitor how amacrine neurites contribute to the formation of 
the IPL, Godinho and colleagues followed individual cells from the time their 
neurites first elaborate until they stratify (Godinho et al. 2005). Capturing the 
behavior of amacrine cells prior to their arrival at the interface with the nascent 
IPL, they showed that during migration, amacrine cell processes did not appear 
to be polarized towards their eventual target, the IPL. Instead, they had multiple 
processes emerging from their cell body that were highly dynamic. Even when 
amacrine cells were detected near the border of the IPL and the forming INL, 
they continued to elaborate processes that appeared to sample the environment 
(Fig. 5 A). Once the processes of amacrine cells reach the form
amacrine cells project their neurites exclusively t
another  phase of dynamic remodeling, resulting in
the cell’s lateral territory
lateralize preferentially within the appropriate su
amacrine cells directly recognize sublamina
(Fig. 5 B). These findings demonstrate 
neurites is highly directed and does not involve extensive laminar
(Fig. 5 C). The selective elaboration of amacrine neurites with
or OFF sublaminae in the IPL suggests the
(Godinho et al. 2005)
Figure 5. (A-B) In vivo
first elaborate until they stratify.
nascent IPL the amacrine cell processes had multipl
that were highly dynamic.
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elaborate processes that appeared to sample the environment. At this point amacrine cells 
project their neurites exclusively towards the GCL, and enter into another  phase of dynamic 
remodeling, resulting in an arbor that demarcates the cell’s lateral territory within the forming 
IPL. The amacrine arbors lateralize preferentially within the appropriate sublamina, indicating 
that the amacrine cells directly recognize sublamina-specific cues in the forming IPL (Adapted 
from Godinho et al. 2005). C) Proposed sequence of amacrine cell neurite development from 
serial EM studies (Adapted from Morgan and Wong 2005; Hinds and Hinds, 1978). 
As already mentioned, direct cell-cell interactions, rather than molecular 
gradients, are the more likely candidates for such cues. This is because, 
compared with other CNS regions in which molecular gradients set up specific 
axonal arborization patterns (e.g. the tectum or superior colliculus), the IPL is 
relatively thin and compact.  In the IPL, such molecular gradients would need to 
be very steep to set up not only the ON and OFF sublaminae, but also the 
multiple strata that lie within each sublamina, as they are only micrometers 
apart (Wassle and Boycott, 1991; Werblin et al., 2001). One of the most 
attractive model addresses a key role of adhesion molecules.  A large number 
of cell-cell adhesion molecules are expressed in stratified patterns in the IPL 
(Wohrn et al.1998; Honjo et al 2000; Drenhaus et al 2003, 2004). In support of 
this model, disruption of Plexin function, a cell surface co-receptor that mediates 
the repulsive effects of Semaphorins, results in a failure of IPL formation in the 
chick retina (Ohta et al, 1992). Another adhesion molecule, N-cadherin, may 
function specifically to promote proper targeting and lamination of retinal 
neurons (Masai et al 2004). Recent evidence implicates two members of the 
immunoglobin supefamily of adhesion molecules, Sidekicks1 and 2, as direct 
sublamination guidance cues in the chick retina. Sidekick1 and 2 (Sdk1 and 2), 
have been shown to be differentially expressed in the ON and OFF sublaminae 
of the chick IPL: Sdk1, expressed in the ON sublamina, has been implicated in 
establishing connections between ganglion, amacrine and bipolar cells that co-
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stratify in this sublamina, whereas Sdk2 has been implicated in establishing 
connectivity in the OFF sublamina (Yamagata et al. 2002). 
Despite the numerous advances in understanding how retinal neurons develop 
and the relationship between form and function in the retina, there are still many 
outstanding issues. Finding direct stratification regulators is not an easy 
challenge since the factors implicated in this complex process usually perform 
multiple developmental function, moreover the circuit formation may rely on 
integration of multiple redundant mechanism that simply render it unsusceptible 
to the loss of individual molecules. 
1.3 From the Retina to the Brain 
The correct assembly of the wiring in the retina is needed to modulate the visual 
stimuli, which are then transmitted to the visual processing centers in the brain. 
This important role is accomplished by the RGCs whose axons, forming the 
optic nerve, wire the eye to the brain. As for the other retinal neurons, the 
establishment of functional neural circuits includes three-sequential events: a) 
the polarized outgrowth of axons and dendrites; b) the axon pathfinding, which, 
in this case, occurs over long trajectories; and c) the recognition of the 
appropriate synaptic partner (Fig. 6). 
The growth of retinal ganglion cell (RGC) axons to their tectal targets is perhaps 
one of the best understood cases of axon navigation over an entire pathway. 
Axon navigation relies on the competence of growth cone to sense and interpret 
attractive and repulsive cues present along their trajectory, since the earliest 
phases of the process. 
The polarized outgrowth of axons and dendrites
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Growth cones then adopt a complex morphology when t
the brain entry point. F) G
optic chiasm. G) Axons
and undergo dramatic morphological changes
form a topographical map
surface (Dingwell, Holt and Harris, 2000).
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Components of the extracellular matrix  (e.g., laminin, fibronectin) and a variety 
of cell adhesion molecules (CAMs: IgG superfamily, cadherin families) and 
substrate adhesion molecules (SAMs, integrins) have been shown to promote 
neurite initiation (Hynes and Lander, 1992). The integrin complex is a structural 
component of focal adhesions and acts as a link between the plasma 
membrane and the extracellular matrix (ECM) (Fig. 7A). Substrate-adhesion is 
essential for generating the forces required for axon outgrowth, but may not be 
sufficient for promoting axonogenesis. Focal adhesions are not only sites that 
couple the plasma membrane with the cytoskeleton, but are also 
macromolecular signaling complexes (Giancotti and Ruoslahti, 1999). 
Composed of both structural (e.g., cytoskeleton-binding) and signaling proteins, 
focal adhesions play important roles in axon outgrowth signaling mechanism in 
addition to cell adhesion. In fact, in addition to CAMs and ECM, axon initiation 
and outgrowth in the visual system depends on growth factor receptors, such as 
the fibroblast growth factor receptor (FGFR), expressed in RGC growth cones 
(Fig.7B). 
The axon pathfinding:
The RGCs growth cone is  responsible to sense and interpret attractive and 
repulsive cues, and the dynamics of growth cone morphology varies in a 
position-specific manner during the development of the visual projection: at 
different points along the optic pathway, it tends to be more complex at points 
where important pathway decisions or choice points are made (Harris et al., 
1987; Holt, 1989). Growth cones tend to be simple during outgrowth and then 
acquire a more complex morphology as they reach and turn at key decision 
points, supporting the idea that these changes reflect responses to cues within 
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their microenvironment. One of the most dramatic changes in the morphology of 
RGC growth cones occurs when axons leave the ganglion cell fiber layer and 
enter the optic nerve head (Fig. 6 E). In this region the growth cone meets an 
important signaling cue, Netrin-1 (Fig. 7 B, C).  
Netrin-1 is  a laminin-related secreted protein, produced by glial cells at the 
optic disk and optic nerve head that appears to act at a short-range to attract 
RGC growth cones into the optic nerve head. This effect is mediated by 
signaling involving the netrin-1 receptor, Deleted in Colorectal Cancer (DCC) 
expressed on RGC axons (de la Torre et al., 1997). Restricted co-expression of 
laminin-1 and netrin-1 at the entrance to the optic nerve head results in a 
repulsive signal that serves to ‘push’ the growth cone away from the retinal 
surface and grow deep into the attractive netrin-1-rich/laminin-1-poor optic 
nerve head. Netrin-1 is expressed in the optic disk/nerve head but also further 
along the optic tract (Fig. 6 G) where it governs RGC axon guidance with a 
repulsive action. Intrinsic changes in RGC growth cones and extrinsic factors 
present in the optic tract might modulate the progressive maturational change 
that occurs in RGC growth cones in response to netrin-1. Netrin-1 functions as 
a repellent in the distal part of the visual pathway and helps to constrain the 
growth of RGC axons into the appropriate trajectory. In the tract between the 
optic nerve head and the optic chiasm the RGC axons are insensitive to Netrin-
1. In that point the RGCs growth cones show the second dramatic change in 
their complexity (Fig. 6 F). 
The optic chiasm is an important choice point along the visual pathway where 
RGC axons have to decide whether or not to cross the ventral midline of the 
brain. The degree of decussation of RGC axons at the optic chiasm varies 
according to the species. Fish and birds have no binocular vision and only 
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crossed projections. In most mammals, all RGCs located in the temporal retina 
send axons ipsilaterally, whereas in species with less binocular vision 
uncrossed projections arise from a subpopulation of RGCs in the 
ventrotemporal (VT) region of the retina. The Eph (erythropoietin-producing 
human hepatocellular)  family of tyrosine kinases receptors is the largest known 
subfamily of receptor. For Eph receptor activation is required the direct binding 
with their corresponding ephrin ligands. Because Eph receptors are expressed 
at high levels in the ventrotemporal retina (Cheng et al., 1995; Drescher et al., 
1995), the stage-dependent Eph– ephrin interactions at the chiasm could 
account for the ipsilateral projection. Ephrin-B ligand forms a repulsive ‘barrier’ 
at the chiasm that repels the subpopulation of EphB expressing fibers into the 
ipsilateral tract. Only this restricted RGC subpopulation in mouse VT retina 
express a different receptor EphB1 (Williams et al. 2003), responsible for Eph-
ephrin interaction needed for ipsilateral projections. 
Then the orderly advance of RGC growth cones, is achieved by an integrated 
response of the growth cone to a variety of environmental cues acting either 
from a distance through diffusion gradients or by local short range effects that 
include cell–cell interactions (Tessier-Lavigne and Goodman, 1996).  Netrin and 
Eph/ephrin molecules belong to the growing list of guidance molecules that 
have been shown to contribute to the accurate development of visual 
projections. Although they play diverse roles, they share the ability to exert bi-
functional activity on growing RGC axons, they are reused along the visual 
pathway and their role is conserved among vertebrate species. 
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The recognition of the appropriate synaptic partner:
Once  they reach the border of their target, the optic tectum (or superior 
colliculus in mammals), growth cones undergo a rapid and remarkable change 
in behavior (Fig.  6 H, J). Their growth rate decreases significantly and they lose 
their characteristic morphology, becoming highly complex and elongated with 
lamellipodia and filopodia extending in all directions (Fig. 7 D, E). These 
changes could be due to a switch in the extracellular environment to one that 
does not favor axon growth. Molecules that are highly expressed along the optic 
tract, drop off significantly within the anterior tectum.  
One simple model to explain these observations is that during target 
recognition, growth cones sense a change in FGFR signaling (FGF2 levels), 
likely from high to low, which then triggers their morphological and behavioral 
changes. The final result is growth cones switch from active growth to 
arborization.  
Figure 7. Some of the molecules that regulate RGC growth c
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and tectum, respectively, are partially responsible for appropriate topographical 
mapping (Cheng et al., 1995; Drescher et al., 1995). 
1.4 Morphogen guidance cues activate internal signaling cascade at 
growth cone 
Axon navigation depends on the competence of growth cones to sense and 
interpret guidance cues, along their trajectory. Recently it was demonstrated 
that the axon guidance process regulation does not relies only on a restricted 
number of conserved family of ligand-receptor signaling systems (e.g. 
Netrin/DCC, Ephrin/EPH, Slit/Robo, Semaphorin/Plexin), but some neurons 
respond also to other secreted signaling molecules, best known for their roles 
as morphogens in early embryo development, belong to  the Sonic hedgehog 
(SHH), Wingless (WNT) and Transforming Growth Factor/Bone Morphogenetic 
Protein (TGF- /BMP) signaling pathways (see for review Bovolenta, 2005; 
Sanchez-Camacho and Bovolenta, 2009). 
Morphogens are secreted proteins produced by a restricted group of cells that, 
emanating away from their sources, induce distinct cellular responses in a 
concentration-dependent manner. Binding to specific receptors, morphogens 
activate particular intracellular cascades that influence cell behavior in a vast 
number of processes. Recent evidence show that they are not only involved in 
the early phases of embryo development, but are also reused as axon guidance 
cues at later developmental stages (Bovolenta, 2005). 
Among morphogens, members of the TGF- /BMP families have been 
implicated in neuronal polarization (Yi et al. 2010), axon and dendrite 
development (Kerrison et al.2005; Hocking at al.2007) and axonal pathfinding 
(Augsburger et al. 1999; Butler and Dodd, 2003), processes that require rapid 
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and local changes in cytoskeletal organization and plasma membrane 
components. In fact, as already mentioned, growing axons respond to gradients 
of chemo-attractant or chemo-repulsive cues translating the external differences 
into an intracellular signal that could activate different cascades for the different 
morphogens. In many cases, these intracellular signaling cascades result in the 
transcriptional activation of nuclear gene targets. However, in the case of axon 
guidance the participation of nuclear gene transcription may appear a slow and 
uneconomic way to control local growth cone movement. In fact, the growth 
cone advance, pause or transformation seem to largely rely on fast and local 
changes in cell adhesion and cytoskeletal organization mostly due to activation 
of local protein synthesis and degradation within the growth cone, events that 
may allow compartmentalized modifications and thus steering. 
It was demonstrated that the TGF- /BMP  morphogens mediate axon guidance 
using a transcription-independent pathway. BMP receptor dimerization in 
growth cones activates an alternative and completely transcription-independent 
cascade that culminates in local cytoskeleton regulation. This alternative 
pathway involves the activation of LIM Kinases (LIMK1 and 2), which in turn 
phosphorilate and inactivate an Actin Depolimerization Factor (ADF/Cofilin), 
permitting axon polymerization to occur. Interestingly, prolonged exposure to 
BMP ligands changes the response from an attraction to a  repulsion. This 
change involved the activation of Slingshot (SSH), a phosphatase known to 
counteract the effect of LIMK1 on ADF/Cofilin, leading to its activation that 
results in repulsion (Wen et al. 2007) (Fig. 8).   
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Cues induce rapid translation of cytoskeletal proteins or regulator based on 
whether they are attractive or repulsive: proteins induced by attractive cues 
build up the cytoskeleton, whereas proteins induced by repulsive cues break it 
down. Attractive cues such as Netrin-1 and BDNF induce b-Actin synthesis, in 
particular this occurs asymmetrically in response to a gradient of netrin-1 or 
BDNF (Yao et al, 2006). On the other hand, repulsive cues such as Slit2b and 
Sema3A induce local synthesis of actin depolymerising molecules such as 
Cofilin and RhoA (Fig. 10). 
Accumulating evidence shows that local protein synthesis (PS) activation in 
axons and growth cones is also achieved by activation of translation initation 
factors via mitogen-activated protein kinase (MAPK) and mammalian target of 
rapamycin (mTOR) which activates translational initiation by phosphorylating its 
two major substrates 4E-BP1 and S6K (Campbell and Holt, 2001, 2003). 
Eukaryotic initiation factor 4E (eIF-4E) binds the 5’ cap of mRNAs and is the 
rate-limiting factor for cap-dependent translation. Hypophosphorylated eIF-
4Ebinding protein (eIF-4EBP) sequesters eIF-4E, preventing the recruitment of 
the rest of the translation initiation complex, while phosphorylation of eIF-4EBP 
releases eIF-4E, thus activating translation (Gebauer and Hentze, 2004). The 
axon guidance cues induce phosphorylation of eIF-4EBP via MAPK and mTOR 
pathway and activate eIF-4E by direct phosphorylation via MAPK and Mnk-1 
(Campbell and Holt, 2003; Piper et al, 2006). The activation of MAPK pathway 
is also responsible for mTOR regulation. In fact mTOR activity is positively 
regulated by a GTP-bound form of RHEB GTPase, which is inactivated by its 
GTPase-activating proteins TSC1 and TSC2 . Since TSC1 and TSC2 are 
negatively regulated by AKT and ERK1/2, the guidance cue cascade activate 
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1.5  MicroRNAs 
MicroRNAs (miRNAs) are short non-coding RNAs that are viewed as 
fundamental regulators of cell function (Bartel, 2009;Carthew et al. 2009). 
MiRNAs are approximately 20–25 nucleotides (nt) long and are generated from 
double stranded RNA precursors. First discovered in C. elegans, (Lee at al. 
1993; Wightman et al 1991, 1993), miRNAs are present in both plants and 
animals and constitute an essential component of gene regulation (Lee at al. 
2001; Lau et al.2001; Lagos-Quintana et al.2001; Pasquinelli et al.2000). As 
summarized in figure 12, miRNAs are transcribed in the nucleus, either 
independently or as part of introns of protein coding genes (Newman et al 2010; 
Siomi et al 2010). Genes of functionally related miRNAs are often clustered on 
the same chromosome, and expressed as a single primary transcript (pri-
miRNA). These transcript are generated mainly by RNA polymerase II (Lee et 
al. 2008). Similar to other Pol II transcripts, pri-miRNAs possess a 5’ cap and a 
3’ poly-A-tail (Cai et al. 2004). Within the primary transcripts, miRNAs form 
stem-loop structures, which contain the mature miRNA as part of an imperfectly 
paired double stranded stem connected by a short terminal loop. In the 
canonical miRNA biogenesis pathway, these structures are recognised by the 
microprocessor complex, a multiprotein complex with two core components, 
Drosha and Di George Syndrome critical region gene 8 (DGCR8). The double-
stranded RNA binding protein DGCR8 binds to the base of the stem loop 
structure and thereby guides the positioning of the RNase III enzyme Drosha, 
which constitutes the catalytic center of the complex (Han et al.2006). Drosha 
cleaves the double-stranded stem about 11 bases from the base and generates 
a two nucleotide (nt) overhang at the 3’ end (Gregory et al 2004, Han et al. 
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2006). This cleavage reaction liberates a hairpin-shaped RNA molecule of 70–
100 bases called miRNA precursor or pre-miRNA. 
The pre-miRNAs are specifically recognised by the nuclear export receptor 
Exportin 5 and exported in a Ran-GTP dependent manner (Lund et al. 2004; Yi 
et al. 2003; Bohnsack et al. 2004). In the cytosol, the pre-miRNA is further 
processed by the RNase III enzyme Dicer (Grishok et al. 2001). This enzyme 
binds the 3’ overhang of the pre-miRNA with its PAZ domain and thereby 
positions the substrate correctly for the cleavage by the two catalytic domains 
22 bases upstream within the double stranded stem (Macrae et al. 2006; Zhang 
et al. 2004). The result of Dicer cleavage is a double stranded RNA of 22 bases 
in length. One of the strands (the mature miRNA) strand interacts with a 
member of the Ago protein family to form a miRNA-induced silencing complex 
(miRISC),  whereas the other strand (the star (*)-strand) is degraded or also 
loaded in another miRISC. In mammals, the strand selection and RISC 
assembly is accomplished by a complex that contains Dicer, Ago and the 
double stranded RNA binding protein TRBP (Chendrimada et al. 2005; Haase 
et al. 2005; Gregory et al.2005). Statistical analyses have discovered that 
generally the strand with the less stable base pairing at the 5’ end is chosen as 
guide strand (Khvorova et al. 2003; Schwarz et al. 2003). Core components of 
the miRISC include proteins of the argonaute (AGO) family that directly bind the 
miRNA and GW182 family proteins which mediate translational repression and 
mRNA decay. The miRNA guides the complex to partially complementary target 
mRNAs. Most of the target sites are located within the 3’ untranslated region 
(UTR) of mRNAs. However, functional miRNA binding sites in the 5’ UTR as 
well as in the open reading frame have also been reported (Orom et al. 2008; 
Tay et al. 2008).  Nucleotides 2–8 of the miRNA are particularly important for 
pairing with the target mRNA. This sequence motif is referr
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miRNA-guided regulation of gene expression has been implicated in every 
cellular pathway. Each cell type expresses a specific subset of miRNAs to 
ensure that cell type-specific mRNA profiles are established and maintained. 
For example, expression of a neuron-specific miRNA in non-neuronal cells 
results in shifting the global gene expression program towards transcript profiles 
typically found in neurons (Lim et al.2005). miRNAs may be acting in both 
neuronal remodeling and maintenance of neuronal connections and their roles 
may be due to the spatial temporal specificity of their expression. Among the 
multiple classes of sequence-specific RNA regulatory mechanism that 
contribute in the control of maturation and plasticity in neurons, the role of 
microRNAs in shaping the neuronal landscape has only begun to be explored. 
The knowledge about individual miRNA functions was initially obtained by 
studying miRNA expression profiles in the nervous system (Wienholds et al. 
2005). Experiments using both loss and gain of function have been very 
informative in the role that miRNAs play at the level of individual neurons and 
neuronal cell biology, giving us information about the importance of their spatial 
and temporal control (e.g. Giraldez et al., 2005; Leaman et al., 2005; Krutzfeldt 
et al., 2005; Lanford et al., 2010). The possible contribution of miRNAs to 
neuron plasticity can be schematically summarized dividing them into two major 
category, as depicted in Fig. 13.
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Some miRNAs play different roles at different developmental stages. For 
example, the brain-enriched miR-137 has an early role in neural differentiation 
targeting CDK6 (Silber et al., 2008). However, it also controls later processes of 
neuronal plasticity, as it was found to play a key role in adult neurogenesis 
(Szulwach et al., 2010), neuronal maturation (Smrt et al., 2010) and dendritic 
spine growth in which it elicits changes in synapse morphogenesis largely 
through regulation of the ubiquitin ligase Mind Bomb-1 (Smrt et al., 2010). Also 
neurotransmitter pathways were examined such as dopamine signaling, which  
was shown to increase the expression of miR-181a in primary neurons. 
Overexpression and knockdown of miR-181a in primary neurons demonstrated 
that miR-181a is a negative posttranscriptional regulator of GluA2 surface 
expression, spine formation, and mEPSC frequency in hippocampal neuron 
cultures, establishing a key role for miR-181 in response to neurotransmitters at 
the synapse (Saba et al., 2012). 
miR-134 was identified in hippocampal neurons as a dendritically localized 
miRNA, and it functions to negatively regulate the size of dendritic spines 
through the inhibition of LimK1, one of the regulator of actin dynamics already 
mentioned in the previous chapters. This negative regulation was demonstrated 
in hippocampal neurons in vitro (Schratt et al., 2006) and in Xenopus spinal 
neurons in vivo (Han et al. 2011). 
miRNAs that act as positive regulator of dendritic spine development and 
synaptic connection:
Even if the cases of miRNAs with negative impact on synapse regulation are 
the majority of the reported cases in literature, there are also reported cases of 
miRNAs that act as positive regulator of dendritic spine development and 
synaptic connection, such as miR-124, miR-125, miR-132, miR-188, miR-212 
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and miR-263 (Rajasethupathy et al. 2009; Edbauer et al., 2010; Muddashetty et 
al., 2011; Magill et al. 20120; Lee et al. 2012; Im et al. 2010; Hollander et al. 
2010; Yang et al. 2008). Among them, an example of positive regulation of 
dendritic spine development is observed in the case of miR-125b, whose 
overexpression results in longer, thinner processes of hippocampal neurons. 
Fragile X mental retardation protein (FMRP)  knockdown is shown to ameliorate 
the effect of overexpressed miR-125b on spine morphology. It has been 
proposed that miR-125b negatively regulates its target NR2A, along with FMRP 
and AGO1 (Edbauer et al., 2010). Recently, a mechanism was proposed 
whereby FMRP phosphorylation provides a reversible switch in which AGO2 
and miR-125 form an inhibitory complex on PSD-95 mRNA, thus turning off 
mGluR signaling. However, dephosphorylation of FMRP and subsequent 
release of Ago2 activates mGluR signaling (Muddashetty et al., 2011). This 
switching mechanism could provide the means for temporal and spatial control 
of translation. 
These and other observations imply that there are multiple layers of complexity 
in the regulatory logic of miRNAs in dendritic morphogenesis (see for a review 
McNeill and Van Vactor,  2012).  
Signaling pathways are highly interconnected, and the flow of information they 
carry is controlled by many feedback loops. This renders their functionality more 
similar to a network rather than to a linear cascade. In these networks, miRNAs 
are crucial elements of regulative loops. The miRNAs can act as signaling 
amplifiers: regulating inhibitors of a signaling cascade they impact on signal 
strength or duration, or empowering cell responsiveness to otherwise sub-
threshold stimuli. A miRNA could simultaneously target distinct branches of a 
signaling cascade/network, or could impart specificity to the signaling flow by 
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channelling it towards  specific branches. Different miRNAs, such as miR-126, 
miR-21 and miR-26a, are reported to target both positive or negative regulators 
of the two pleiotropic pathways RAS-RAF-MAPK and PI3K-AKT cascade (Fish 
et al. 2008; Kuhnert et al. 2008; Meng et al. 2007; Thum et al. 2008; Huse et al. 
2009). The involvement of miRNAs in feed-forward and feed-back motifs makes 
them important elements in the understanding of signaling pathways properties 
in the coordination of tissue induction, growth and morphogenesis (see for 
review Inui, Martello and Piccolo 2010; Inui, Montagner and Piccolo 2012). 
Another issue that increases the complexity of this crosstalk between growth 
factor signaling and miRNAs, is the identification of an emerging group of 
proteins that can modulate pri-miRNA processing by the microprocessor 
complex in response to diverse stimuli. For example, activation of Smad 
proteins by stimulation of cells with bone morphogenic protein (BMP) or tumour 
growth factor  (TGF-) can stimulate the maturation of specific miRNAs. This 
activity is Co-Smad4-independent and leads to increased recruitment of the pri-
miRNAs to the microprocessor complex, enabling a more efficient cleavage by 
Drosha (Davis et al. 2008) (Fig.14). 
Figure 14. Regulation
BMP signaling stimulates the production of pre
processing by controlling
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regulation of miRNA maturation by associating
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1.6  MicroRNAs in the eye
Congruent with the complexity of visual system 
miRNA expression analyses have revealed a remarkabl
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the vertebrate retina  (Karali et al. 2007, 2010; Hackler et al. 2010; Krol et al. 
2010b; Xu et al. 2007; Wang et al. 2010; Ryan et al. 2006). 
miRNA transcriptome analyses provided the first clues about the importance of 
miRNA gene regulation in the retina. About 80 different miRNAs were initially 
identified in adult mouse retina by microarray, 23 of which were preferentially 
expressed in retina as compared to other tissues (Xu et al. 2007; Loscher et al. 
2007; Karali et al. 2010). 
Subsequently Karali et colleague in Banfi’s lab present the first analisys of 
miRNA expression in ocular tissues, using both microarray and RNA in situ 
hybridization (ISH) procedures. Using a microarray approach, they determined 
the expression profiles of miRNAs in the retina, lens, cornea and retinal pigment 
epithelium of the adult mouse eye. Each tissue had notably distinct miRNA 
enrichment patterns and cluster analysis identified groups of miRNAs that 
showed predominant expression in specific ocular tissues or combinations of 
them. They also  performed RNA in situ hybridization (ISH) for over 220 
miRNAs, including those showing the highest expression levels by microarray, 
and generated a high-resolution expression atlas of miRNAs in the developing 
and adult wild-type mouse eye, which is accessible in the form of a publicly 
available web database. (Karali et al. 2010). 
Studying retinal pathologies in animal models allowed the identification of 
miRNAs putatively involved in disease progression, and recent findings also 
suggest that miRNAs will be useful targets for the prevention or treatment of 
retinal degenerative disorders. miRNAs have been shown to promote the 
survival of both rod and cone photoreceptors (e.g. Zhu et al. 2011; Sanuki et al. 
2011), a crucial finding as photoreceptor cell death is the primary cause of 
blindness in retinal degenerative diseases. These results make miRNAs and the 
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pathways they control attractive targets for the design of therapeutics to prevent 
or ameliorate various retinal degenerative disorders (Zhu et al. 2011) . 
Constitutive disruption of the pre-miRNA processing enzyme Dicer leads to 
early death in embryonic development in mice (Bernstein et al. 2003) However, 
conditional knockout (CKO) of Dicer has become the most common technique 
used to assess the phenotypic consequences of miRNA gene regulation loss in 
selected tissues.  
Effects on eye development of global perturbation of miRNA activity:
Conditional Dicer knockout has revealed roles for miRNAs both in retinal 
development and in the physiology and survival of mature retinal neurons 
(Damiani et al. 2008; Georgi et al. 2010; Iida et al. 2011; Pinter et al. 2010).  
Recently, four different retinal Dicer CKO mouse models suggested that 
miRNAs play diverse roles in the development and physiology of the 
mammalian retina. Dicer CKO driven by the Chx10-cre transgene led to 
decreased electroretinogram (ERG) responses, morphological anomalies, and 
progressive retinal degeneration (Damiani et al. 2008). Pax-6cre-driven Dicer 
CKO resulted in abnormal differentiation of retinal cell types (Georgi et al. 
2010), and Dkk3-cre or Rx-cre driven Dicer deletion led to widespread 
apoptosis of retinal progenitors (Iida et al. 2011; Pinter et al. 2010), a phenotype 
consistent with the effect of Dicer disruption in Xenopus (Decembrini  et al. 
2008).  
Effects on eye development of perturbation of specific miRNAs:
Genetic loss-of-function studies are beginning to disclose the physiological roles 
of specific miRNAs or miRNA clusters in the  vertebrate retina. Studies 
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performed in frogs, fish, and mice are beginning to identify the phenotypic and 
molecular consequences of specific miRNAs loss-of-functions. 
Walker and Harland in 2009 reported that inhibition of miR-24a in Xenopus 
resulted in increased apoptosis of retinal precursors, leading to reductions in 
eye size. They demonstrated that miR-24a  targets the pro-apoptotic factors 
caspase-9 and apoptosis protease-activating factor 1 (apaf1), important for the 
survival of neuroretinal progenitors (Walker and Harland, 2009). 
Decembrini and colleagues hypothesized that miRNAs exhibiting differential 
expression during retinal patterning might play a role in regulating the cell fate 
and differentiation of retinal cell types. They demonstrated that simultaneous 
inhibition of a set of miRNAs (miRs -129, -155, -214, and -222) expressed early 
in Xenopus retinal development could, through de-repression of the homeobox 
genes otx2, and vsx1, promote differentiation of additional retinal bipolar cells, a 
late-developing retinal cell type.  
Zhu et al, recently evaluated the role of the miR-183/96/182 cluster in rods. 
These three miRNAs are enriched in rod and cone photoreceptors, exhibit 
similar seed region sequences and are predicted to share common mRNA 
targets. Prior to this work, functional redundancy of the three miRNAs was 
hypothesized based on results obtained in Zebrafish. Morpholino-induced 
knockdown of all three miRNAs produced auditory system morphological 
defects that were more severe than those resulting from knockdown of miR-96 
alone, or miR-182 and -183 together (Li et al. 2010). To analyse the cluster 
function in the retina, a miR-183 cluster sponge transgenic mouse model was 
developed. When the visual system of transgenic mice was stressed with 
intense light, they documented a dramatically increased sensitivity to light-
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induced retinal degeneration causing the death of ~80 % of rods in the superior 
retina, due to the loss of miRNAs-cluster action on Casp2 (Zhu et al. 2011) 
Using the Medakafish (Oryzias latipes) as a model system, Conte and 
colleagues, recently demonstrated that loss of miR-204 function resulted in an 
eye phenotype characterized by microphthalmia, abnormal lens formation, and 
altered dorsoventral (D-V) patterning of the retina, which is associated with optic 
fissure coloboma. These phonotypes were in part due to the abnormally 
elevated levels of the transcription factor Meis2, identified as one of the main 
targets of miR-204 function (Conte et al. 2010a).  
As for the miR-204, another example of how a specific miRNA can regulate 
multiple events in eye formation is miR-124. Down regulation of this miRNA in 
mice cause specific apoptosis of newly differentiated cone photoreceptors and 
pronounced defects in the CNS. This cone cell death was partially rescues 
reducing the levels of a miR-124 target gene, Lhx2, a homeobox transcription 
factor required for eye development (Sanuki et al. 2011). More recently Baudet 
et al, in Holt lab, demonstrated that loss of miR-124 delayed the onset of 
Sema3A sensitivity and concomitant neuropilin-1 (NRP1) receptor expression 
and caused cell-autonomous pathfinding errors of RGC axons. CoREST, a 
cofactor of a NRP1 repressor, was newly identified as a miR-124 target, whose 
dysregulation cause the delay in RGC growth cone responsiveness. This study 
demonstrates miR-124 is important in regulating the intrinsic temporal changes 
in RGC growth cone sensitivity and suggest that miRNAs may act broadly as 
linear timers in vertebrate neuronal development. Moreover this represented the 
first report of a robust RGC axonal phenotype due to a knockdown of a single 
miRNA (Baudet et al. 2012). 
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1.7  Oryzias latipes as a model system to study developmental defects 
Studies of individual microRNAs function is challenging for several reasons: 
first, microRNAs are frequently present as families of apparently redundant 
members that share the same seed region in which case it would be necessary 
to eliminate all the loci in order to dissect their global function; second, each 
miRNAs has numerous putative targets that have disparate functions, prediction 
based only on seed sequence compatibility may not be able to establish a priori
which transcript is most meaningful and thus worthy of experimental validation; 
third, the degree of target down-regulation tends to be quantitatively modest, 
leading to a maximum of decrease of 50% of a target protein levels. This 
require time and high costs in mammalian species, such as mouse,  whereas  in 
a simpler vertebrate species, Oryzias latipes (Medakafish), it is possible to 
perform gain and loss of function studies in a easier way to identify the function 
of  an individual microRNA, as already demonstrated in recent work published 
in Banfi’s lab (Conte et al. 2010a). 
Medakafish is a particularly amenable model system for this kind of analysis 
since its use is less time and resource consuming, as compared with 
mammalian systems and mouse in particular (Ishikawa, 2000).  Physiology, 
embryology and genetics of Medakafish have been widely studied in the past 
100 years. Already in 1913, the Medakafish was used to show Mendelian 
inheritance in vertebrates (Ishikawa, 1913; Toyama, 1916). Then, genetic 
studies on Medakafish, have been focused on the molecular basis of 
pigmentation and sex determination (Baroiler et al. 1999; Wada et al. 1998; 
Matsuda et al. 1998, Matsuda et al.1999, Yamamoto T. 1958). In the past few 
years, this model was a very useful tool to identify and/or characterize some 
important genes involved in the eye development (Fukada et al. 1995: Simeon 
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A. 1998, Zhou et al. 2000; Chaing et al.1996; Macdonald et al.1995; Ekker et 
al.1995; Mathers et al.2000; Conte and Bovolenta 2007; Kitambi et al. 2008; 
Ruiz et al. 2009; Conte et al. 2010a, 2010b; Alfano et al. 2010; Beccari et al. 
2012).  
In addition, the complete sequencing of its genome has greatly contributed to 
the use of this model to study various biological processes underlying the 
embryonic development. Different comparative studies among vertebrates have 
demonstrated a high conservation in terms of genomic sequences and 
molecular processes, also in model systems such as teleost (Danio rerio / 
Zebrafish and Oryzias latipes / Medakafish). Zebrafish and Medakafish are very 
close species: they separated from their last common ancestor about 110 
million years ago. They are both ideal organisms for genetic studies as they 
display many advantages such as the simple use of different genetic 
engineering techniques. They have a short generation time (8-10 weeks for 
Zebrafish and 6-8 weeks for Medakafish). Moreover Zebrafish/Medakafish 
biology allows ready access to all developmental stages, and the optical clarity 
of embryos and larvae allow real-time imaging of developing pathologies. 
In particular, unlike other teleost, Medakafish has several advantages. 
Medakafish is very hardy and tolerates a wide range of salinities and 
temperatures (10–40 °C); it is easy to breed and hi ghly resistant to common fish 
diseases. For all the above-mentioned reasons, thus, Medakafish is easier to 
keep and maintain in aquaculture than Zebrafish and it is easier to handle. Early 
Medakafish development is slower than in Zebrafish: Zebrafish larvae hatch 
after 2–3 days, whereas Medakafish embryos are enclosed in a tough chorion 
that protects them in their natural habitat until they hatch as feeding young 
adults after 8 days. This slower development at the early phases allow to better 
define and characterize developmental processes
and Medakafish are considered an ideal model to study eye developm
(Wittbrodt et al., 2002)
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From the experimental point of view, however, the two model systems are 
completely equivalent. In both systems, reverse-genetic analyses are also 
facilitated by assays of gene function using transient rather than stable 
misexpression, which is technically easier than in mice. Microinjection of early 
embryos with either mRNA or antisense morpholino oligonucleotides results in 
transient gene overexpression or knockdown, respectively (Wittbrodt et al., 
2002).  
The above reasons demonstrate that fish represent  mainstream models in 
developmental biology. Their attributes have propelled the rise of fish as a 
model in developmental biology and human diseases research, allowing an 
enhanced understanding of the basic cell-biological processes that underlie the 
development and the disease phenotype of the specific genetic diseases 
(Lieschke and Currie, 2007; Wittbrodt et al., 2002).  
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AIM OF THE THESIS 
My project attempted to elucidate the functional roles of microRNAs (miRNAs) in 
the regulatory networks necessary for the proper development of the vertebrate 
eye, by following these specific aims: 
 Identification and characterization of  miRNAs preferentially expressed in the 
developing vertebrate eye: a group of eye-enriched miRNAs of interest was 
chosen through the analysis of their sequence conservation and conserved 
expression profile to proceed with their functional characterization.
 Screening and functional analysis of the identified eye-enriched miRNAs by 
gain- and loss-of function studies using Medakafish (Oryzias latipes) as model 
system: Functional characterization was performed by manipulating the miRNAs 
activities in Medakafish embryos through loss- and gain-of-function screening
obtained respectively by injections of morpholino (Kloosterman et al. 2007) and 
of miRIDIANTM  Dharmacon microRNA Mimics. The possible eye developmental 
defects during the embryo development were analyzed by morphological 
inspection and detection of modification in the expression of eye developmental 
markers by RNA in situ hybridization analysis, qRT-PCR,  immunohistochemistry 
and Western Blot experiments.
 Identification and functional characterization of mRNA targets for the selected 
eye-enriched miRNAs:  the list of the predicted target genes for the miRNAs of 
interest, was analysed and, among them, I selected, based on previous 
expression and literature data, those targets that were more likely to play a part
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in the genesis of the observed phenotype. Once confirmed their expression level 
variation in the in vivo model, by qRT-PCR and Western Blot, I proceeded with 
the experimental validation (Luciferase assay) needed to demonstrate the direct 
binding of the selected miRNA to the 3’UTR of the putative target gene. Finally, 
a possible phenotype rescue (morphological and/or molecular) was sought to 
demonstrate the functional role of the identified mRNA target in the genesis of 
the observed eye phenotype. 
This project allowed me to gain insight into the role of miRNAs in retinal and 
ocular development and functions, ultimately leading to the enrichment of our 
understanding of retinal and ocular biology, but also of miRNA-related 
molecular bases of retinal and ocular diseases. 
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2. MATERIALS AND METHODS 
2.1 Medakafish Stocks 
Wild type Oryzias latipes of the cab strain were maintained in an in-house 
facility in a constant re-circulating system at 28°C on a 14 hours light/10 hours 
dark cycle. Embryos were staged according to Iwamatsu 2004 (Iwamatsu, 
2004). 
2.2 Morpholinos (MO), mRNAs and Mimic injections
To inhibit miR-181a and miR-181b functions, specific morpholinos (MO) (Gene 
Tools) were designed on the two different  miR-181a/b mature sequence as 
follow:  
Mo-miR-181a    AACTCACCGACAGCGTTGAATGTTC (25b) 
Mo-miR-181b    AACCCACCGACAGCAATGAATGTTG (25b) 
The following MOs containing five mismatches (mm-MO) with respect to the 
MO-miR-181a and Mo-miR-181b sequences were used as control (mismatches
are in red): 
mm-Mo-miR-181a    AAGTCAGCGACACCGTTCAATCTTC (25b) 
mm-Mo-miR-181b    AAGCCACGGACACCAATCAATCTTG (25b) 
MOs were injected in a range of concentrations (0,03 - 0,12 mM). Their 
efficiency was measured as the ability of interfering with eGFP expression using 
a reporter construct. The pCS2/miR-181a-GFP and pCS2/miR-181b-GFP 
reporter plasmids were constructed cloning the comp
MOs in the eGFP 5’UTR sequence. The PCR products fo
miR-181b sequences
(miR181a/Fc 5’- GATCGAACATTCAACGCTGTCGGTGAGTT 
5’- TAGCAACTCACCGACAGCGTTGAATGTTC 
AACATTCATTGCTGTCGGTGGGTT 
TAGCAACCCACCGACAGCAATGAATGTT 
was inserted in the  pCS2+ vector eGFP mRNA and RFP
and transcribed out of pCS2+ vector using the SP6 m
(Ambion) according to manufacturer instructions. Th
quantified and re
Yamagami, 1975). MOs were individually co
mRNAs (25 ng/µL) and RFP mRNA (25 ng/µL). 
Figure 16. Schematic representation of the cloning strategy 
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The inhibitory efficiency of each MO was measured by quantification of the 
green/red fluorescence ratio (eGFP/RFP) intensity using Photoshop CS3 
software (Adobe) to measure average pixel intensity of RFP and eGFP, as
previously reported (Conte et al., 2010b; Esteve et al., 2004). Selected MO 
working concentrations was 0,03 mM for Mo-miR-181a and 0,03 mM for Mo-
miR-181b. Control embryos were always co-injected with either eGFP mRNA or 
mmMOs to follow the efficiency of the injections as well as for testing possible
defects associated with the injection procedures. Activation of p53 is an 
occasional off-targeting effect of MO injections (Robu et al., 2007), and can be 
counteracted by injection of a p53 Mo (Eisen and Smith, 2008). Thus possible 
non-specific effects of  MOs were ruled out by coinjecting it with a Mo designed 
against Medakafish p53 (p53MO) (Conte et al., 2010b). 
All the injection solutions included 25 ng/µL of eGFP mRNA as a lineage tracer. 
To inhibit both miR-181a/b the two morpholinos were co-injected into one 
blastomere of the embryos at the one-two cell stage and the optimal MOs total 
concentration (0.12 mM mo-miR-181a +0.12mM mo-miR-181b) were 
determined on the basis of morphological criteria. For the overexpression 
experiments miRIDIAN (Dharmacon) miRNA Mimics for miR-181 were injected. 
Different concentration from 0.5 µM to 2 µM were tested, and the final 
concentration was determined on morphological criteria. At both 1 µM and 2 µM 
the embryos showed the same phenotype and all the experiments were 
perfomed at a final concentration of 2 µM. The control embryos were injected 
with a Negative Mimic (Dharmacon)  at the same concentration. 
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2.3 Transformation of E.coli with plasmid DNA 
E.coli DH5 cells were prepared for transformation as follows: cells were grown 
to mid-log phase (A600=0.6) in Luria Broth (LB: 1% bactotryptone, 1% NaCl and 
0.5% Bacto-yeast extract) at 37˚C with shaking. Cells were harvested by 
centrifugation at 2000 x g at 4˚C, resuspended into 100ml (for each 100ml of 
culture) of 50% CaCl2. This suspension was then centrifuged at 5000 x g for 15 
min at 4˚C. The resulting pellet was resuspended into 100ml (for each 100ml of 
culture) of 50% CaCl2 and centrifuged again. The cells were resuspended in 3 
ml of ice cold 10% glycerol solution, aliquoted and stored at -80˚C. For each 
transformation, DNA was added to 50 µl of competent cells, and incubated in 
ice for 20 min; then cells were subjected to heat shock at 42˚C for 2 min and 
successively incubated on ice for 10 min. Cells were recovered in 1 ml of LB 
and incubated for 40 min at 37˚C, before plating on LB-agar containing 
appropriate antibiotics. Plates were incubated at 37˚C overnight to allow 
bacterial colonies to grow (Sambrook and Russell, 2001).  
2.4 Isolation of plasmid DNA from E. coli
Mini-preps plasmid DNA preparations were carried out using the QIAGEN MINI 
prep kits. Procedure is based on the alkaline lysis method (Sambrook and 
Russell, 2001), but using a support column to purify isolated plasmid DNA. One 
aliquot of plasmid DNA was diluted in 1:200 in milliQ water, and the 
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concentration was determined according to the following formula: absorbance of 
one A260 unit indicates a DNA concentration of 50 µg/ml.  
2.5 Whole-Mount In Situ Hybridization  
Whole-mount in situ hybridization was carried out as using digoxygenin-labeled 
antisense RNA riboprobes. Antisense and sense cDNA templates were 
obtained by RT-PCR amplification of total RNA from Oryzias latipes at different 
stages of development with the appropriate oligonucleotide primers. These PCR 
products were then cloned into the Topo TA vector (Invitrogen). This vector 
contains two different promoter sequences (T7 and Sp6) for the expression of 
both the sense and antisense strands of the cloned product. The cDNA of the 
olERK2 gene were isolated by RT-PCR amplification with the following specific 
primers:  
Name Forward Reverse 
o.l.erk2 probe F  5'- ATTTCGGTCTGGCCCGTGTG -3' R  5'- GGTTGAGCTGATCCAGGTAG-3' 
Totalcds o.l.erk2 F  5'- ATGGCGACAGCTGCGGTGTC -3' R  5'- GGGACCTGAACCCGGGCTGAA -3' 
To synthesise RNA probes the reaction mix was set up as follow: 
1µg of linearized plasmid/PCR product 
2 µl of 10X transcription buffer (Roche) 
2 µl of DIG-labelling mix (Roche) 
2 µl of appropriate RNA polymerase (T3, T7, SP6)-40 Units (Roche) 
1 µl of RNase inhibitor 
DEPC H2O 
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The reaction mix was incubated for two hours at 37˚C, after which 2 µl (20 
Units) of DNase-RNase free was added to the reaction mix and incubated for 15 
minutes at 37˚C to degrade template DNA. 80 µl of H2O were added to the 
reaction followed by precipitation with 0.1 volume 4M LiCl and 3x volume 
absolute ethanol at -20˚C for two hours. The probe was then centrifuged at 
2000 x g for 30 minutes at 4˚C, washed with 70% ethanol, air-dried, dissolved in 
40 µl of DEPC H2O and stored at -20˚C. 
Selected embryos were fixed in 10 ml of 4% paraformaldehyde prepared in 2X 
in 2X PTW (PBS containing 0.1% Tween) for 1 hour at room temperature and 
then 12 hours at 4°C. The embryos were dechorionate d and washed 4 times 
with 1X PTW. Finally, embryos were dehydrated in methanol 100% and stored 
at -20°C (embryos in methanol endure to several mon ths of storage without 
degeneration).  
Embryos were gradually rehydrated washing with 75% methanol/PTW, 50% 
methanol/PTW and 25%methanol/PTW. Than samples, were treated with 
10mg/ml 
proteinase K in PTW for a different amount of time (from 5 to 90 minutes) 
depending on the specific embryonic stage and washed twice with freshly 
prepared 2mg/ml glycine in PTW. After the embryos were refixed in 4% 
paraformaldehyde/PTW at room temperature for 20 minutes and washed 
through five changes of PTW. The embryos were pre-hybridized for at least 1 
hour at 65°C (42°C for microRNAs LNA-DIG-probes) wi th hybridization buffer 
prepared as follow:  
Formamide 100% 25ml 
SSC 20X (pH7.0) 12.5 ml 
Heparin (50mg/m) 150 l,  
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Torula-RNA 250 mg 
Tween20 10%.  
The probes were added and the samples were hybridized overnight at 65°C 
(42°C for microRNAs LNA-DIG-probes). After the hybr idization step, embryos 
were washed at 65°C (42°C for microRNAs LNA-DIG-pro bes) with 50% 
formammide/2xSSCT, 2xSSCT and 0.2xSSCT. Then the embryos were 
incubated at room temperature with a blocking solution (5% serum/PTW) for 
two hours in agitation. The samples were then incubated for 12 hours at 4° with 
200 µl of anti-DIG antibody (1:4000 dilution). Then the samples were washed 3 
times for 10 minutes with the SB solution (0.1M Tris pH 9.5, 0.1M sodium 
chloride, 50 mM, Magnesium chloride, 0.1% Tween). Subsequently the 
embryos were placed in the appropriate colour solution with specific reagents 
NBT / BCIP (Boehringer). 
The reaction was blocked with TE/Tween 0.1% solution, the embryos were 
again fixed in 4% paraformaldehyde/PTW for 20 minutes, washed with PTW1X 
and stored in glycerol. The embryos were embedded in a mix of BSA/Gelatine 
and sectioned with vibratome. Bright-field images were obtained on a Leica DM-
6000 microscope. Adobe Photoshop was used to adjust image brightness and 
contrast. A minimum of 20 embryos, obtained from independent injections, were 
hybridized for each marker and condition. 
2.6 Richardson Romeis staining (Histo Blue sections) 
Solutions
Borax Solution: Solve 1g Borax (Borax = Sodium tetraborate decahydrate)in 
100ml ddH2O ( 1% Borax solution) with the aid of magnetic stirrer/heater 
o Filter 1% Borax solution 
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Blue Solution: Add 1g Methylene Blue in 100ml 1% Borax solution ( 1% 
Methylene Blue in 1% Borax solution) 
Azur Solution: Solve 1g Azur II in 100ml ddH2O ( 1% Azur II solution) 
Richardson Romeis solution: Mix 1% Azur II solution and 1% Methylene Blue in 
1% Borax solution at a ratio of 1:1 ( Richardson (Romeis) staining solution) 
Filter Richardson (Romeis) staining solution 
Staining
• Apply the staining solution briefly on slide on heater (60°C) 
• Throw it away (special waste  heavy metals!) 
• Wash briefly with tap water 
• Left them over night in water 
• Dry slide on heater 
• Coverslip  
2.7 Immunofluorescence analysis 
For the immunofluorescence analysis on the Medakafish sections, embryos 
were fixed overnight in 4% paraformaldehyde in PTW at 4°C, incubated 
overnight in 15% sucrose/PTW at 4°C and than incuba ted overnight in 30% 
sucrose/PTW at 4°C. The cryosection of control and morphant Medakafish 
embryos were washed three times with PBS1x (-Pax6, -Calretinin, - Otx2) 
or PTW 1x (-Rhodopsin, -Syntaxin, -Zpr1, -GS6). Than the slides were 
boiled in Citrate Buffer: 
• Citric acid 1.9 mL 
• Sodium Citrate 8.8 mL 
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• Add water to 200 mL 
For each antibody were used different time of boiling, different blocking buffer 
and different diluite solution that are reported in the table: 
Antibody Boiling time Blocking buffer Diluite solution Concentration Secondary 
antibody 
Rhodopsin 1’ 10%FBS/PTW1x 5%FBS/PTW1x 1:5000  -mouse 
Zpr1 2’ 5%GoatSerum/0.5%Triton in PBS1x 5%FBS/PTW1x 1:200  -mouse 
Syntaxin 2’ 10%FBS/PTW1x 5%FBS/PTW1x 1:100  –mouse 
Otx2 10’ 10%FBS/PTW1x 5%FBS/PTW1x 1:100  –rabbit 
GS6 2’ 10%FBS/PTW1x 5%FBS/PTW1x 1:100  -mouse 
Pax6 8’ 10%FBS/PTW1x 5%FBS/PTW1x 1:250  –rabbit 
Calretinin 5’ 5%FBS/0.3%Triton/PBS1x 1%BSA/0.3%Triton/PBS1x 1:500  –mouse 
ERK1/2 5’ 5%FBS/0.3%Triton/PBS1x 1%BSA/0.3%Triton/PBS1x 1:50  –rabbit 
After the overnight incubation with the primary antibodies, the slides were 
washed three times with PTW1x and than were incubated with the Alexa Fluor 
secondary antibodies (Invitrogen) 1:1000. The slides were counterstained with 
4.6-diamidino-2-phenylindol, DAPI (Vector Laboratories). Slides were 
photographed using LSM710 Zeiss Confocal Microscopy. 
2.8 Transgenic lines 
The Ath5 (del Bene et al. 2007) and Six3.2 (Conte and Bovolenta, 2007) 
transgenic embryos were injected with mm-mo-miR-181a/b (control) and mo-
miR-181a/b (morphants). The embryos were than fixed at the stages of interest 
overnight in 4% paraformaldehyde in PTW at 4°C, inc ubated overnight in 15% 
sucrose/PTW at 4°C and than incubated overnight in 30% sucrose/PTW at 4°C. 
The cryosection of control and morphant transgenic  embryos were washed 
three times with PTW1x and were counterstained with 4.6-diamidino-2-
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phenylindol, DAPI (Vector Laboratories). Slides were photographed using and 
LSM710 Zeiss Confocal Microscopy. 
2.9 Dissection of Medakafish tissue (eye) 
To obtain RNAs or protein extracts from Medakafish embryo tissues was 
necessary remove the chorion (egg envelope) before dissect the tissues. To 
solubilize the chorion the eggs were trated with hatching enzyme.  
Preparation of Hatching enzyme:
Fertilized eggs were collected in numbers ranging from hundreds to thousands, 
and the blastula-stage eggs were rolled between sheets of filter paper to 
remove the attaching filaments. The eggs were growth at 27°C for 7-8 days. All 
the eggs were collected in a tube, washed 4-5- times in bidistilled water. All the 
water was removed and the tube were dipped into liquid nitrogen for 1’ and 
water at 37°C for 1’. The process was repeated thre e times. Than the eggs 
were homogenized with a pestle. The homogenized was centrifuged 1’ at 4°C. 
The supernatant was transferred in a new tube. 250µL of cold PBS1x was 
added and homogenized with a pestle. Centrifuged 1’ at 4°C. The supernatant 
was transferred in a new tube. Other  250µL of cold PBS1x was added,  
homogenized with a pestle and centrifuged 1’ at 4°C . Finally all the supernatant 
was collected in a new tube and centrifuged 10’ at 4°C. The supernatant was 
transferred in a new tube and store at -80°C. 
For efficient chorion solubilization on the outside of the living embryos, the eggs 
were incubated with Proteinase K (20 mg/mL)  for 5 hours with vigorous 
agitation. The eggs were than treated with Pronase for 30’ and subsequently 
with hatching anzyme at 27°C  for several hours unt il the chorions were 
completely digested. 
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2. 10 Real Time PCR 
The stage 32 RNA eye tissues were obtained from control and morphants 
Medakafish embryos. For negative mimic and  mimic-181 over-expressing 
analysis the RNAs were extracted from whole embryos, respectively. The RNAs 
were extracted and digested with DNaseI using RNeasy extraction kit according 
to the manufacturer’s instructions.  
The cDNAs were generated by the Quantitect kit for the qRT-PCR analysis. The 
qRT-PCR reactions were performed with nested primers and carried out with 
the Roche Light Cycler 480 system. The PCR reaction was performed using 
cDNA (200-500 ng), 10 ul of the SYBR Green Master Mix (ROCHE) and 400 
nM primer, in a total volume of 20 ul. The PCR conditions for all the genes were 
as follows: preheating, 95°C for 5 min; cycling, 40  cycles of 95°C for 15 s, 60°C 
for 15 s and 72°C for 25 s. Quantification results were expressed in terms of 
cycle threshold (Ct). The Ct values were averaged for each triplicate. The olHprt
and olGapdh genes were used as the endogenous control for the experiments. 
Differences between the mean Ct values of the tested genes and those of the 
reference gene were calculated as ∆Ctgene = Ctgene - Ctreference . Relative 
expression was analysed as 2-∆Ct. Relative fold changes in expression levels 
were determined as 2-∆∆Ct (Alfano et al., 2005).
The sequences of oligonucleotide primers are summarized in Table 1. 
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Table 1. List of the sequences of the primers used in qRT-PCR experiments. 
Name Forward Reverse 
Ol TGFBR1 F  5'- GAGTCTTTCAAGCGGGCGGA -3' R  5'- CTCCTCCACGGACGGATCTG -3' 
Ol BMPR2. F  5'- GAAACAGGGCCTGCACAACC -3' R  5'- CTTCCAGGGAGCCGCAGTAC-3' 
Ol SMAD2 chr9 F  5'- GCTAAAGAAGACAGGCCAGC -3' R  5'- CCTGATGTATCCCACTGTTC -3' 
Ol SMAD2 chr12 F  5'- CGATACGGCTGGCATCCTGC -3' R  5'- GTGCACATTCTGGTTAGCTG-3' 
Ol SMAD3 F  5'- CTCCTCTGGATGACTACAGC-3' R  5'- CATGCTGTGGGTCATCTGGTG-3' 
Ol SMAD7 F  5' -GGAGGAACCACATACTCGGC -3' R  5'- CCGTTCCCTTGAGGTAGATC -3' 
Ol ERK2 F  5'- GCAGCGACAGCAGATAGTTC -3' R  5'- GCCGAGATGTTGTCCAACAG -3' 
Ol AKT3 F  5'- GAAGTTGCTCACACGCTCAC -3' R  5'- CTCCTCCGTTGACGTACTCC -3' 
Ol WNT11 F  5'- CCGATGCTCCCATGAAGATG -3' R  5'- CAGGATCCAGATACACCATG -3' 
2.11 Construct preparation for Luciferase assay 
The PCR products for the selected human 3’UTR sequences were obtained 
with XbaI tagged primers (or SpeI). The sequences of oligonucleotide primers 
are summarized in Table 2. The digested PCR products were inserted in the 
pGL3-tk-LUC vector digested with XbaI.  
Table 2. List of the sequences of the primers used to amplify human 3’UTR 
Name Forward Reverse 
Hsa-Erk2 F  5'-TCTAGAGTGACACGGAACAGCACCTC-3' R  5'- TCTAGAGGAAGAAAGCAGAGACGCAG-3' 
Hsa-Akt3 F  5'- TCTAGAGACATCACCAGTCCTAGCTC -3' R  5'- TCTAGAGCTGCCTTAGTAAAATGCCC-3' 
2.12 Trasfection of HeLa cells for luciferase assay
The HeLa cells were plated at the concentration of  135000 cell/mL  in a 24-
multi well. The cells were cultured overnight at 37°C and 5% CO2 in DMEM 
supplemented with 10% FBS, penicillin (100 U/ml) and streptomycin (50 mg/ml). 
The cells were transfected with 370ng of DNA using PolyFect transfection 
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reagent (Qiagen) according to the manufacturer’s instructions. For each vector 
the trasfection was performed in duplicate. After 7 hours the cells were 
trasfected with 50nM of negative mimic or mimic181 using ITERFERIN 
(Polyplus) according to the manufacturer’s instructions. The cell were growth 
overnight at 37°C and 5% CO2 in DMEM supplemented w ith 10% FBS, 
penicillin (100 U/ml) and streptomycin (50 mg/ml). 
After 24 hours the cells were lysed using Passive Lysis Buffer 1x (Promega) 
and the luciferase activities were quantified using the LAR and STOP solution 
(Promega). 
2.13 Western Blot 
The stage 32 eye proteins were obtained from control and morphants 
Medakafish embryos. For negative mimic and  mimic-181 over-expressing 
analysis the proteins were extracted from whole embryos. The proteins were 
extraxted in RIPA buffer.  
The Bradford Reaction was used to detect the proteins concentration of each 
sample using BIO-RAD. 
The protein were loaded on acrylammide gel for SDS-PAGE separation. 
GEL PREPARATION:                            
 LOWER 12% LOWER 15% UPPER 
H2O 3,3 mL 2,3 mL 6 mL 
ACRIL 
33% 
4   mL 5 mL 1,25   mL 
Tris HCL 
pH8.8                
2,5 mL 2,5 mL 2,5m L 
(pH6.8)  
SDS 10%                         100uL 100uL 100uL 
TEMED 10 uL 10uL 10 uL 
APS 10%                            100uL 100uL 100uL 
66 
For each sample was loaded a range of 15-30 ug of protein (diluited in SDS 
10%, Tris HCL pH6.8, Glycerol, Bromophenol Blu, beta-mercaptoethanol).                                 
The runs were performed for 2 hours at 100-120V. Than the proteins were 
transferred of a Nitrocellulose Membrane (filter BIO-RAD), for 90 minutes at 
300mA. 
The proteins were colored with PONCEAU-RED solution, than the filters were 
washed with TBS 1x, and blocked for 2 hours in MILK 5% in TBST 1x. The 
primary antibodies were incubated overnight. After this incubation the filters 
were washed 3 times in TBST 1x, than incubated with the secondary antibodies 
1 hour at room temperature. The filters were washed 3 times in TBST 1x and 
the antibodies were revealed with ECL kit according to the manufacturer’s 
instructions.  
2. 14 Primary culture of Medakafish retinal cells 
Slides treatment:
• wash  70% EtOH for 30’ 
• wash  absolute EtOH for 30’ 
• Let them dry 
• Sterilize them in autoclave 
• Treat the slides with Poly-D-Lysine 20µg/ml in bidistilled water overnight at 
37°C 
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• Rinse 3 or 4 times with bidistilled water 
• Treat the slides with  Laminin 10 µg/ml (PBS 1x) overnight at 37°C 
• Rinse 3 or 4 times with bidistilled water only before adding the cells 
Primary culture of Medakafish retinal cell:
• Once removed the chorion with hatching anzyme dissect the stage 28-30 eye of 
control or morphants embryo in cold L15 medium supplemented with 10% FBS, 
penicillin (100 U/ml) and streptomycin (50 mg/ml). 
• Once removed the lens collect the eye in  100µL of cold complete L15 medium 
• Add 20µL of Trypsin (10mg/mL in PBS1x) 
• Incubate the eye 10’-15’ at 37°C (shake them perio dically) 
• Add 20µL of Soybin trypsin inhibitor (20mg/mL in PBS1x) 
• Up&down with syringe using a G27 needle  
• Wash the slide (treated with laminin) with bidistilled water  
• Add 500µL of complete L15 + 20µL N2 supplement (100x) medium pre-heated 
at 37 °C to the cells  
• Add the cells to the slide 
• Growth at 30°C  for 24 hours 
2.15 Drug treatments 
Once removed the chorion with hatching anzyme the morphant embryos were 
growth in 96-multi-well with  
• PD98059  25µM 
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• DMSO 3% 
• Yamamoto1x 
For a minimum of 24 hours to a maximum of 6 days. For the control 
experiments the morphants were growth in Yamamoto1x/ DMSO3%. 
For the TGF- treatments the embryos were growth with: 
• TGF- molecule 10 ng/ml 
• DMSO 3% 
• Yamamoto1x 
For a minimum of 24 hours to a maximum of 6 days. For the control     
experiments the morphants were growth in Yamamoto1x/ DMSO3%. 
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3. RESULTS   
3.1 Identification of eye-expressed miRNAs and characterization of their 
expression profiles in Medakafish  
To identify and select eye-enriched miRNAs, I took advantage of already 
published catalogs of microRNA expression profiles. In Banfi’s laboratory, the 
expression of 13 miRNAs (miR-9, -29c, -96, -124a, -181a, -181b, -182, -183, -
184, -204, -213, -216, and -217) during eye development in the mouse was 
previously determined (Karali et al. 2007). Their variable spatial and temporal 
profiles suggested their involvement in modulating diverse aspects of ocular 
and retinal function. Subsequently, the knowledge about microRNAs 
preferentially expressed in the eye was expanded with two different miRNA 
microarray profiling experiments which allowed us to obtain information on: 1) 
miRNAs enriched in the eye with respect to the rest of the embryo and 2) 
miRNAs showing preferential expression in each of the three main 
compartments that compose the eye: retina and RPE, lens and cornea (Karali 
et al. 2010).  
Among them, I aimed at identifying a selected subset of eye-enriched 
microRNAs  to undergo further functional characterization. My aim was to gain 
insight into the role of specific miRNAs in retinal and ocular development and 
function, with the goal not only to improve our understanding of retinal and 
ocular biology, but also to start uncovering the possible contribution of miRNAs 
to the pathogenesis of retinal and ocular diseases.
To functionally characterize these eye-enriched microRNAs, I decided to rely on  
Medakafish fish (Oryzias latipes), a particularly amenable model system to carry 
out gene functional studies (Ishikawa et al. 2000).
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Firstly, I performed a detailed evolutionary comparison of the mature sequences 
of the selected eye-expressed miRNA using the information deposited in the 
NCBI (http://www.ncbi.nlm.nih.gov) and UCSC Genome Bioinformatics 
(http://genome.ucsc.edu) public databases. Moreover, I compared their 
expression profiles across evolution through the analysis of several gene 
expression public database such as EUREXPRESS 
(http://www.eurexpress.org), which stores RNA ISH expression profiles of 
miRNAs in mouse embryos at embryonic day (E)14.5; GEISHA2.0
(http://geisha.arizona.edu/geisha/index.jsp), which collects  in situ hybridization 
for genes expressed in the chicken embryo during the first six days of 
development; and miRNEYE (www.http://mirneye.tigem.it/), which reports the 
previously described miRNA expression data in the mouse eye generated  in 
our lab (Karali et al. 2010). I chose to focus my attention on the microRNAs 
more conserved both in terms of sequences  and expression profile in the eye 
in vertebrates. Based on the above analysis, I finally selected the following 
microRNAs: miR-204, miR-29c, miR-30c, miR-30d, the miRNA cluster 
composed of miR-183 miR-182 and miR-96, mir-184 and the miRNA cluster 
composed of miR-181a and miR-181b. To evaluate  their expression profile in 
the Medakafish eye, I perfomed RNA ISH at different developmental stages with 
LNA (locked-nucleic-acids) templates. Below is a summary of the results 
obtained (Fig. 17). 
MiR-204 was found to be expressed in the optic cup since early stages of eye 
development. In the mature eye, miR-204 was  detected in the RPE, lens 
epithelium cells and in INL and GCL in the retina (Fig. 17 A). The miR-29c, miR-
30c and miR-30d start to be expressed during the final phases of retina 
maturation (stage 36) and at stage 38 they were expressed at low levels in INL, 
IPL and GCL (Fig. 17 B, C, D). The miR
genomically organized in a cluster and present the same expressio
all the cellular layers of the retina but  with a p
photoreceptor layer (Fig. 17 F, G, H). In agreement
in other species (Wienholds et 
et al. 2008; Zhu et al. 2011), among the three micr
most abundant one  (Fig. 17 F). MiR
the developing lens and at stage 38 its expression
epithelial cells (Fig. 17 I). The two miRNAs miR
organized in a genomic cluster, were expressed, sta
differentiating retina and at stage 38 they were bo
at lower levels, in the GCL (Fig. 17 E, J). 
Figure 17. Expression patterns in the Medakafish mature retina
miRNAs selected for the functional characterization
type medakafish embryos at stage 38  hybridized with  LNA
A) miR-204 was detected in the RPE, lens epithelium cells 
D) The miR-29c, miR-30c and miR
183, miR-182 and miR-
the retina but  with a particularly enrichment in t
expressed in the lens epithelial cells. E, J) miR
expressed in the INL and, at lower levels, in the G
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3.2  Initial functional screening for selected eye-expressed miRNAs 
I performed functional characterization  of a selected subset of the previously 
listed miRNAs by knocking-down their activity in Medakafish embryos by using 
a morpholino (MO)-based strategy (Kloosterman et al. 2007). Morpholinos 
oligos are short chains of about 25  Morpholino subunits, completely stable in 
cells, that act via steric blocking mechanism I decided to focus my attention on 
the initial characterization of miR-184, miR-204 and the miRNA cluster formed 
by miR-181a and miR-181b. The morpholino injection for the miR-184 did not 
produce any ocular alteration at lower concentration, whereas at higher 
concentration it featured toxic and unspecific effects. This toxicity at higher 
levels was likely due to off-targeting effects, which are observed in about 15–
20% of MOs used. For these reasons, I did not further pursue this miRNA. 
On the other hand, the morpholino-mediated ablation of miR-204 during eye 
development resulted in an eye phenotype characterized by microphthalmia, 
abnormal lens formation, and altered dorsoventral (D-V) patterning of the retina, 
which is associated with optic fissure coloboma. Using different approaches for 
the miR-204 functional characterization, we demonstrated its role in dorso-
ventral patterning of the optic cup and lens differentiation via Meis2 targeting 
(Conte et al. 2010a). We also demonstrated miR-204 involvement in lens 
migration, axon pathfinding and retina maturation (unpublished data). I was 
deeply involved, in the first two years of my PhD project, in the functional 
characterization of this miRNA. The results of this analysis are part of a 
publication in PNAS, in which I am a co-author, and which is enclosed to this 
thesis as Appendix. 
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The main focus of my thesis, however, has been the  functional characterization 
of the role of the miR-181a/b cluster that displayed a very intriguing expression 
profile during vertebrate eye development, as also described above. The 
remaining part of my thesis will therefore describe the results of this 
characterization. 
3.3 Genomic organization of the miRNA cluster miR-181a/b and detailed 
expression analysis in Medakafish 
I started the miR-181a/b characterization by first studying their sequences and 
genomic organization in Medakafish, that turned out to be very conserved with 
respect to the mouse and human genomes. The cross-species comparison of 
the mature miR-181a and mature miR-181b demonstrated that their sequences 
are completely identical among vertebrates (Fig. 18 A). As shown in figure 18 A, 
the two microRNAs presented only three bases of difference, none of which is 
located in the seed region. This evidence strongly suggests that these two 
microRNAs could recognize the same set of mRNA targets. 
In the human and mouse genome, two copies of the miR-181a/b mature 
sequences are present. In human, the miR-181a-1 and miR-181b-1  copies are 
located on chromosome 1, in an intron of a poorly characterized non-coding 
RNA gene (LOC100131234), whereas the miR-181a-2 and miR-181b-2 copies 
are located on chromosome 9 and overlap in opposite orientation an intronic 
region of the  nuclear receptor subfamily 6, group A, member 1 gene (NR6A1) 
that encode for an orphan nuclear receptor, member of the nuclear hormone 
receptor family (Fig. 18 B). I found the same organization in the mouse genome: 
the miR-181a-1 and miR-181b-1  copies are located on chromosome 1, in an 
intron of a not yet classified product identified in adult male testis cDNA 
(AK076660), and the miR
in the locus of the
(Nr6a1) (Fig.18 B). In human and mouse it is also 
181-related sequences, which is formed by miR
respectively from miR
same seed sequence. In the Medakafish genome, I did
181c and miR-181d mature sequences, but I identified four miR
(on chromosome 9, chromosome 17, chromosome 4 and o
105) (Fig. 18 A), suggesting that during evolution 
of this clusters thus leading 
Figure 18. Characterization of miRNA
across the vertebrate species
mature miR-181b demonstrated that are completely conserved amo
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microRNAs presented only three bases of difference, not  located in the seed region. B) 
Schematic representation of human, mouse and medakafish genomic organization of miR-
181a/b clusters. In human genome the two copies of miR-181a/b clusters are located on 
chromosome 1 in an intron of the non-coding gene LOC100131234, and on chromosome 9 
overlapping in opposite orientation an intronic region of NR6A1. In mouse genome the two 
copies of miR-181a/b clusters are located on chromosome 1 in an intron of a not yet classified 
product identified in adult male testis cDNA (AK076660), and on chromosome 2 in the locus of 
NR6A1. In the Medakafish genome are present four miR-181a/b clusters on chromosome 9, 
chromosome 17, chromosome 4 and on the Ultracontig 105. 
As previously mentioned, I used LNA-probes directed against miR-181a and 
miR-181b mature sequences  to determine the expression profile of these two 
miRNAs in Medakafish by RNA ISH. At early stages of development, i.e., stage 
24 and stage 28, it was not possible to detect a signal for neither microRNA, 
(Fig. 19 A a, b, f, g). However, starting from stage 30  the expression of both 
miRNAs was evident in the inner part of neural retina  (Fig. 19 A c, h). This 
spatio-temporal profile suggest a miR-181a/b expression in differentiating 
amacrine cells. It is also to be noted that this particular stage corresponds also  
to the beginning of the plexiform layer formation. At later stages of eye 
development, stage 36 (Fig. 19 A d, i) and stage 38 (Fig. 19 A e, j) the two 
miRNAs were expressed at high levels in the INL and GCL, with a stronger 
staining in the INL in proximity of the IPL, where amacrine cells are located (see 
magnification in Fig. 19 A e’, j’). Moreover their expression was also present in 
other organs and in the developing Central Nervous System (CNS). As shown 
in figure 19 B, at latest stage of development I detected their expression in the 
telencephalon, in the optic tectum and in the medulla oblongata, with a very 
strong staining in the optic tectum (Fig. 19 B a’).
Figure 19. Expression patterns of miR
RNA ISH on frontal sections of wild
and miR-181b (f-j’) at St 24 (a, f),
miRNAs start to be detectable by ISH at stage 30 in
cells (c, h). Note that at stage 30 starts also the plexiform 
development, st36 and st38, both miRNAs are express
B) On lateral section of medaka
levels in Optic Tectum. ONL: Outer Nuclear Layer; I
Plexiform Layer; GCL: Ganglion Cell Layer; T: Telen
Cerebellum; MO: Medulla Oblongata
3.4 Knockdown of 
retinal inner plexiform layer
To determine and analyze the 
development, I employed antisense morpholinos
gene knockdown. I
miR-181a (mo-miR
This approach should guarantee the block of all the
miRNAs, regardless of their genomic origin. 
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To further ensure that the morpholinos were able to bind and block the miRNAs, 
I constructed and coinjected with the morpholinos a Green Fluorescent Protein 
(GFP) reporter plasmid, in the  5’UTR of which I inserted the miRNA mature 
sequences. In particular, I created two different constructs for the two different 
miRNAs (5’UTR-miR-181a-eGFP and 5’UTR-miR-181b-eGFP, see materials 
and methods). If the corresponding morpholino properly binds the miRNA 
mature sequence, it should also downregulate GFP translation which should 
reflect in a reduction of, green fluorescence signal. To obtain a quantitative 
assessment of GFP repression by the morpholinos, RNA coding for Red 
Fluorescent Protein (RFP) was also coinjected and the green/red fluorescence 
ratio was quantified, as previously described (Conte et al., 2010b; Esteve et al., 
2004). As illustrated in figure 20 the reporter plasmid 5’UTR-miR-181a-eGFP 
(injected alone in fig. 20 A a, a’)  was translationally repressed when coinjected 
with mo-miR-181a (Fig. 20 A c, c’). However, coinjection of the same construct 
with a mutated form of the mo-miR-181a (mm-mo-miR-181a, see Methods), did 
not lead to translation downregulation of the GFP reporter (Fig. 20 A e, e’) 
further supporting the specificity and quality of my controls.  
Using the other construct 5’UTR-miR-181b-eGFP (injected alone in fig. 20  A b, 
b’), it was possible to assess the specificity of mo-miR-181b in binding and 
blocking the miR-181b mature sequence. In fact the GFP reporter plasmid was  
translationally repressed when coinjected with mo-miR-181b (Fig. 20 A d, d’), 
whereas coinjection with the mm-mo-181b  was not able to repress GFP 
translation (Fig. 20 A f, f’). 
Moreover I coinjected the plasmid 5’UTR-miR-181a-eGFP with the not 
corresponding morpholino mo-miR-181b (Fig. 20 A g, g’), and the plasmid  
5’UTR-miR-181b-eGFP with mo-miR-181a (Fig. 20 A h, h’). These co-injections 
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did not lead to decrease in  GFP production, indicating that the three bases of 
difference between the two miRNAs were sufficient to avoid the binding with the 
not corresponding morpholino. Together these data demonstrate that the 
morpholinos designed against the two miR-181 mature sequences were able to 
bind with high efficacy the two miRNAs and to block specifically their functions. 
To test if these interactions occurred also in vivo on the endogenous miRNAs, I 
performed an RNA ISH experiment on control and morphant embryos. As 
schematically described in figure 20 B, in control embryos, the LNA-probes 
were able to bind miRNAs mature sequences, whereas in morphants embryos, 
the binding of the morpholinos to the miRNAs mature sequences prevented the 
LNA-probe interaction with their complementary sequences, i.e., the miRNAs. I 
hybridized the LNA-probes, against miR-181a and miR-181b, separately on 
control and co-injected embryos (mo-miR-181a+mo-miR-181b). I did not detect 
any staining for each probe in co-injected embryos (Fig. 20 B a’, b’) compared 
to the control embryos (Fig. 20 B a, b), demonstrating that the morpholinos 
were specifically able to inhibit the miRNAs and therefore abolish their functions 
in vivo. Together, these results indicated that injecting only one morpholino I 
was able to specifically inhibit only the corresponding miRNA. Since miR-181a 
and miR-181b display the same seed region and are predicted to share their 
main mRNA targets, I decided to co-inject both corresponding morpholinos to 
block miR-181a and miR-181b together and avoid redundancy effects. 
Figure 20. Mo-miR-181a and mo
mature sequences respectively.  
assess efficiency of the two Mos designed to block 
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181a and miR-181b expression was not detected in morphants.
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The mo-miR-181a and  mo-miR-181b morpholinos were co-injected at 1–2 cell 
stage and then the embryos were phenotypically analyzed. Morphological 
inspection using stereomicroscopy did not highlight gross eye defects. Indeed 
the co-injected embryos seemed to be quite similar to the control embryos (Fig. 
21 A e B). However, by analyzing their retinal sections, it was possible to 
observe a specific eye phenotype, characterized by the notable thinning of the 
Inner Plexiform Layer (IPL) (Fig. 21 A’ and B’ red lines). 
This phenotype was observed in 87% of injected embryos (76736 out of 88200 
injected embryos). I used the Richardson-Romeis staining to mark the 
morphological structure of the retina in control and morphant embryos. This 
staining allowed me to precisely discriminate the retina cell bodies from the 
plexiform structures, where the nervous termination form synapses. Using the 
ImageJ software I could determine that the extent of thickness reduction of the 
IPL in morphant fish with respect to controls was of about 48%, quantified as 
the ratio between the IPL area and the total retina area (Fig. 21 C).  
It has been reported that an activation of p53 could represent a non specific off-
targeting effect of some morpholinos (Robu et al., 2007). This non specific 
activation can lead to activation of cell death pathways and the generation of a 
variety of aberrant phenotypes. In the latter scenario, the phenotype can be 
rescued by co-injection of the morpholino against the sequence under study 
and that of p53 (Eisen and Smith, 2008). Therefore, to exclude this possibility, I 
co-injected the (mo-miR-181a and mo-miR-181b) morpholinos with p53-MO 
(Conte et al., 2010b) and no amelioration of the phenotype was observed. This 
result indicated that the activation of p53 does not play any role in the 
generation of the phenotype observed after injection of mo-miR-181a/b. 
  
Figure 21. Knockdown of miR
plexiform layer (IPL).
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respect to control retinas( C ).
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3.5 Knockdown of miR-181a and miR-181b leads to retinal axogenesis 
defects  
In order to verify whether the effects of the miR-181 loss-of function were 
restricted to the above described IPL thickness defects as well as to better 
dissect this retinal defects,  I started to analyze the expression of several 
markers for the different retinal cell types. I analyzed, by immunofluorescence 
analysis using appropriate antibodies:   
- rod and  cone markers, such as Rhodopsin (Fig. 22 A, A’) and Zpr1 (Fig. 22 B, 
B’) respectively;  
- Otx2 (Fig. 22 C, C’), a bipolar cells marker;  
- Syntaxin (Fig. 22 D, D’) a marker of amacrine and retinal ganglion cells 
(RGCs) synaptic terminals;  
- GS6 a marker of Muller glia cells (Fig. 22 F, F’);  
- two markers of two different amacrine cell subtypes, i.e., Calretinin (Fig. 22 G, 
G’) and Pax6 (Fig. 22 H, H’).  
This analysis was performed at two different stages, stage 38 when the retina is 
already mature, and stage 40, i.e., after hatching. At both stages no differences 
in the expression of all markers were observed between control and morphant 
embryos, with the exception of Syntaxin whose staining further highlighted the 
IPL defect in mo-miR-181a/b-injected embryos. Moreover the 
immunofluorescence staining for different amacrine cells type (Fig. 22 G, G’, H, 
H’) and the count of Pax6 positive cells (Fig. 22 I), indicated that there were no 
changes in the number of this subtype of amacrine cells morphant embryos, 
rejecting the  hypothesis that the decrease in IPL thickness could be due to the 
absence of a retinal cell type whose axons and/or dendrites arborized in the 
IPL.   
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Therefore, after having established that there were no differences in retina cell 
type generation, differentiation or organization in layered structures, I decided to 
investigate more deeply the IPL defects taking advantage of two different 
transgenic lines. In these lines, cytoplasmic eGFP was expressed under the 
control of retina cell type-specific promoters, which allowed the visualization of 
the fluorescent reporter in the axons and dendrites of a specific retina cell type. 
The first line that I used was the Six3.2:eGFP line, in which the eGFP was 
under the control of the Six3.2 promoter, studied by Conte and Bovolenta in 
2007. The Six3.2 promoter drives the eGFP expression in amacrine cells. As 
shown in figure 23 (A, A’), the concomitant down-regulation of miR-181a and 
miR-181b  cause defects in the axon formation of this subtype of amacrine 
cells. The red arrows (Fig. 23 A’) indicate different processes emerging from a 
single cell body, instead of one specified axon as observed in control (Fig. 23 
A). Further studies are needed to establish if this processes are multiple axons 
or immature processes that are not correctly specified in axon or dendrites. 
Overall, these data allowed me to determine that miR-181a/b have a role in 
axogenesis of amacrine cells.  
The use of the Ath5:eGFP transgenic line allowed me to characterize the effects 
of miR-181a/b down regulation on the axogenesis  of RGCs, another retinal 
neuronal cell type in which the two miRNAs are expressed. In this line, 
developed by Del Bene and colleague (Del Bene et el. 2007) the Ath5 promoter 
drives the expression of eGFP in the cytoplasm of RGCs, highlighting their 
axonal structure bundled in the optic nerve. Using this line, it was possible to 
study the optic nerve formation from the eye to the optic tectum. 
The down-regulation of miR-181a and miR-181b in this line caused no defects 
in the optic nerve bundle. I found that RGC axons crossed correctly at the optic 
chiasm (Fig. 23 B, B’) but along the optic tract t
area, and did not correctly innervate the optic tec
defects were observed in 67% of the injected embryo
Ath5:eGFP injected embryos).
Figure 23. Knockdown of miR
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These data demonstrate that the miR-181a/b loss-of-function in Medakafish 
caused axogenesis defects leading to an impairment in the correct assembly of 
visual circuits.  

3.6 Knockdown of miR-181a and miR-181b leads to RGCs axon length 
defects 
The in vivo analysis allowed me to identify axogenesis defects in absence of 
miR-181a/b function, but to elaborate further on this observation and better 
define the axonal phenotype, I decided to use an in vitro system. In particular I 
cultured Medakafish RGCs. Since there were no previously described protocols 
for culturing Medakafish retinal neurons, I set up the optimal conditions in which 
the Medakafish cultured cells could survive and form stable  neurites. To further 
characterize the RGCs axons phenotype, I dissociated Ath5 transgenic line eye 
and plated the cells onto a laminin-covered slide around  stage 28-30, I.e., 
when RGC axons start to be bundled in the forming optic nerve. After 24 hour at 
30°C,  the cells were fixed, photographed at micros cope and the axon length of 
control and morphant cells was analyzed using the ImageJ software. I analyzed 
the axon length of 100 control cells and 100 morphant cells, derived from 
different experiments and different injections. In agreement with the in vivo data, 
analysis of primary culture of Medakafish RGCs, demonstrated axon length 
defects in the 80% of morphant cells. I observed a reduction in RGC axon 
length of about 70% in morphant RGCs with respect to controls (Fig. 24).  
These data allowed me to uncover the involvement of miR-181a/b in the 
regulation of RGC axon growth, as assessed by the reduction in  axon length 
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following their loss of function. These experiments also indicated that these 
axon defects are RGCs cell-autonomous and did not depend on altered 
information that could derive from the surrounding tissues. However other and 
different experiment will be needed to determine whether the branching defects 
of RGCs axons at the optic tectum are secondary effects due to these axon 
growth defects or are due to the loss of miR-181a/b function in optic tectum 
neurons.  
With the in vitro analysis of Medakafish RGCs primary cultures, it was not 
possible to investigate on the miR-181a/b role in axon specification because the 
in vitro cultured RGCs have the ability to polarize intrinsically and form 
pseudopodia and filopodia. One of these extension soon shows a conspicuous 
growth cone and begin to grow faster than the others becoming the principal 
axon (Zolessi et al. 2006). Also in the in vivo condition, the developing RGC 
axons emerge directly from uniformly polarized cells in the absence of other 
neurites (Zolessi et al. 2006). This implicate the presence of a different 
mechanism for axon specification between the RGCs and amacrine cells. For 
these reasons to further investigate about the miR-181a/b role in amacrine axon 
specification, I will determine the best in vitro culture condition to analyze 
amacrine axon formation in control and morphant eye explantation, using a 
different Medakafish transgenic line (Six6).  
Figure 24. Knockdown of miR
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3.7 Knockdown of miR-181a and miR-181b leads to visual functional 
deficits 
The above described defects in the wiring of IPL and axon branching of RGCs 
in the brain could also lead to functional defects of visual stimuli elaboration. A 
valid tool for the assessment of visual function is represented by the 
measurement of Optokinetic Response (OKR). The OKR is a stereotyped and 
compensatory eye movement in response to movements in the surround. The 
OKR serves to stabilize the visual image of an object in movement on 
the retina, and allows for high resolution vision. Due to its high selection value, 
all vertebrates display this basic behavior. When the environment is 
continuously moving in one direction, the OKR produces a nystagmus 
composed of cycles of slow eye movement in one direction and a fast resetting 
movement, called saccade, in the opposite direction. The OKR is triggered by a 
fast and directional input coming from the retina and encoded by a neural circuit 
involving pretectal nuclei. For these reasons this behavioral test is appropriate 
to determine reduced or limited vision due to defects in the assembly of retina 
circuits or defects in the brain elaboration of visual stimuli. In collaboration with 
Sara Barbato, a PhD student in our lab, and Stephan Neuhauss at the 
University of Zurich, I was able to demonstrate, that the morphant miR-181a/b 
fish had an impaired OKR. In agreement with the RGC axons defects, 
preliminary data indicated that morphant fish showed a statistically significant 
decrease in the OKR, as shown in figure 25. These data demonstrated that the 
loss of miR-181a/b functions not only led to morphological retinal defects, but 
also to impaired visual function.  
Figure 25. Knockdown of miR
Optokinetic Response (OKR) demonstrate that the miR
function. In the graph are represented the mean ave
morphant (blue line) fishes respect to the variatio
p.value <0,005. 
3.8 miR-181a/b overexpression cause
Using the above described loss
the miR-181a/b involvement in retinal cells axogenesis. In 
inactivation of their activities led to defects in axon spec
neurons and alteration of axon growth in RGCs. To f
role of miR-181a/b in retinal development and function, I decid
gain-of-function studie
overexpression in Medakafish embryos by 
miRNA-181 Mimics
oligonucleotides designed on the basis of miRNA sequences available 
miRBase Sequence Database.
injected at 1–2 cell stage and then 
This approach led to the over
90 
-181a and miR-181b leads to visual functional deficits. 
-181a/b loss-of
rage eye speed of control (green line) and 
n of stimulus contition (increas
s severe early embryonic
-of-function approach I was able to recognize 
ification in amacrine 
urther dissect the functional 
s. Towards this goal, I performed miR
injecting miRIDIAN (Dharmacon) 
. miRIDIAN microRNA Mimics are double
 The miR-181a and miR-
the embryos were phenotypicall
-expression of these miRNAs since the early 
The 
-function impairs visual 
ed contrast). 
 defects 
particular, 
ed to carry out
-181a/b 
-stranded RNA 
in the 
181b Mimics were 
y analyzed. 
91 
stages of development and in all the tissue that derive from the first cells in 
which they were injected. For this reason, there was the possibility that this 
ectopic over-expression had strong impact on possible miR-181a/b targets, that 
are expressed at early stages of development. Among the different 
concentration tested, I observed that at both 1 µM and 2 µM concentrations the 
embryos showed the same phenotype and therefore all the subsequent 
experiments were performed at a final concentration of 2 µM. As negative 
control, Medakafish embryos were injected with a Negative Mimic (Dharmacon)  
at the same concentration used for the miRNA mimics. As shown in figure 26, 
the overexpression of miR-181a/b since early developmental stages caused a 
severe phenotype (Fig. 26 B), characterized by lethality at gastrulation (78%, 
585 out of 750), with the few surviving embryos showing  head defects with 
enlargement of otic vescicle and, in some cases, the complete absence of eye 
structures. Moreover the development of tail structures was severely defected 
resulting in shortened body. These data suggest that some of the miR-181a/b 
targets are already expressed at early stages of development and play 
important roles during gastrulation and developmental processes.  Therefore, I 
could not use this approach to study the direct effects of miR-181a/b 
overexpression in the retina. An alternative strategy that could overcome the 
early lethality caused by miR-181a/b over-expression would be the creation of a 
transgenic line in which the expression of the two miR-181a/b is under the 
control of a tissue- specific promoter, such as Six6 that could drive their 
expression in same retina layer in which they are expressed.  
Figure 26. miR-181a/b overexpression causes severe early embryonic
mimic heteroduplex strategy (Dharmacon) was used to 
181a/b injected embryos show severe developmental defect c
(A) injected with a negative mimic heteroduplex at 
3.9 miR-181a/b target selection and validation assay
The down-regulation of miR
their over-expression altered the correct development of the e
body. I hypothesized that these two phenotypes coul
of miR-181a/b in the regulati
during early stages  of development and then reused
establishment of retinal axon growth processes. To 
level, the roles of miR
necessary to identify their main target genes, whos
underlie the phenotypes observed following their kn
overexpression.  During the past few years, the dev
tools that allow to predict a list
facilitated the identification of the mRNAs targete
tools, such as 
(http://pictar.mdc-berlin.de/
interaction between a microRNA and an mRNA target o
seed sequence presence in the 3’UTR of a trans
sequence among species and  c) strength of this pos
92 
overexpress miR
ompared to the control embryos 
the same concentration.
-181a/b function caused axogenesis defects and 
d be due to a possible role 
on of some signaling pathways, which are needed 
dissect, at the molecular 
-181a and miR-181b during development it
e dosage impairment could 
elopment of bioinformatic 
of possible target genes for each microRNA, 
d by a given microRNA. This 
TargetSCAN (http://www.targetscan.org/
), miRanda (http://www.microrna.org/
n the basis of a) miRNA 
cript, b) conservation of this 
sible interaction, as 
 defects. miRIDIAN 
-181a/b. B) The mimic-
ntire embryo 
 for the correct 
 was 
ockdown and 
), PicTar
),  predict the 
93 
assessed by evaluation of RNA secondary structure. Recently, in our 
laboratory, new tools were developed to  increase the accuracy of these 
predictions, integrating the sequence-based predictions with co-expression 
data, such as in the case of HOCTAR (http://hoctar.tigem.it/) (Gennarino et al. 
2008) and COMETA (http://cometa.tigem.it/) (Gennarino et al. 2012). In 
particular, using the latter tool, I obtained a list of high-confidence predicted  
target genes for miR-181a and miR-181b. I analyzed the list of the common 
predicted targets between the two miRNAs searching in particular for genes 
potentially able to explain the previously described morphant and 
overexpression phenotypes. By analyzing predicted target expression profiles, 
target sites conservation in Medakafish, and literature data I selected a  group 
of ten possible miR-181a/b targets for experimental validation (Fig. 27).  
I analyzed the predicted target gene expression changes in injected Medakafish 
(with Morpholinos or miRNA mimics) by quantitative RT-PCR. To detect the 
effects of miR-181a/b down-regulation on these transcripts, I extracted the RNA 
from eye tissues at stage 32, the first stage at which I observed the IPL 
phenotype, whereas to measure the over-expression effects I extracted the 
RNA at stage 22, when the developmental defects started to be detected. 
As shown in figure 27, I analyzed the two different transcripts that encode for 
SMAD2 (one located on chromosome 9, and the other on chromosome 12), 
SMAD3, SMAD7 and WNT11, that did not show any significant alteration in 
morphant eyes with respect to control eyes. For SMAD2 and SMAD7, I could 
not  exclude that they could be real miR-181a/b targets. Indeed in the over-
expressing embryos they were down-regulated with respect to controls, 
whereas in the morphant eyes, a little increase of these targets in the INL and 
GCL could not be appreciated in these experiments. In this hypothesis the 
absence of increase in the morphant eye could be du
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sites into a luciferase reporter construct, downstream the luciferase cassette 
and upstream the polyA signal. Then I co-trasfected  the luciferase reporter 
construct with miRNA mimics duplex into HeLa cell lines that do not express 
neither miR-181a nor miR-181b. Luciferase activities was tested and 
normalized by a control luciferase activity. I observed a significant decrease of 
luciferase activity only  in the case of the ERK2 3’UTR reporter construct, 
indicating that ERK2 was a real and direct target of miR-181a/b (Fig. 28). On 
the other hand, I did not observe any significant variation of luciferase activity in 
the case of the AKT3 3’UTR reported construct indicating that the observed 
variation in mRNA levels, detected by RT-PCR (Fig. 27), were due to indirect 
effect of miR-181a/b expression alterations. 
Figure 28. Luciferace validation assay. Relative Luc activities in HeLa cells as fold 
differences in the Luc/Renilla ratios normalized to the value of Luc reporter constructs. The 
construct with the ERK2  3’UTR or the AKT3 3’UTR  were co-trasfected with a negative mimic  
or mimic-miR-181. The miR-181 addition decreases Luc activity of the construct containing 3-
UTR of ERK2 when compared with control, whereas no significant variation of luciferase activity 
was detected in the case of the AKT3 3’UTR reported construct compared with control. 
Once I established that there was a direct binding of miR-181a/b on the 3’ UTR 
of the ERK2 transcript, I carried out the luciferase assay using a mutagenized 
human ERK2 3’ UTR. In that case I did not observe any significant variation of 
the luciferase activity demonstrating that the luciferase down-regulation 
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specialized enzymes
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ERK2 3’UTR was due to the miR-181a/b binding, which 
mutagenized construct (Fig. 29 B) 
ERK2 is a real direct miR
-181a/b within the 3-UTR of the ERK2 gene in different species, 
d nucleotides (black); in green is shown 
-181a and miR- 181b. B) Relative Luc activities in HeLa cells as f
ized to the value of Luc reporter constructs. miR
ntaining 3-UTR of ERK2
-181a/b target site in ERK2
ERK2 transcript levels were altered in the 
of protein levels in the miR
s and a decrease in the miR-181a/b over
els. As shown in figure 30 C, 
analysis the increase of 
-181a/b morphant embryos at stage 32. 
n order to become active, it 
oops. This is conducted by 
, the MEKs (MAP kinase kinase). Interestingly by 
-181a/b target. A)
old 
-181 
 when compared with 
 inhibit this effect. 
n western blot 
-
-expressing 
western 
blot analysis, using an antibody that recognize the
detect the increase in morphant eyes of the phospho
protein, and a decrease in over
alteration of ERK2 level
probably of its activity (Fig. 30 A, B). ERK2 repre
because it was already identified as a key player i
including the control of axon gro
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3.10 Interference with miR-181a/b function alters MAPK signaling via 
ERK2 targeting  
ERK2 is a kinase member of the MAPK signaling cascade that is involved in 
different cellular biological functions (see for a review Kyriakis and  Avruch, 
2012). It was demonstrated that in Zebrafish ERK2 down-regulation causes 
severe developmental defects due to the absence of its activity in the regulation 
of actin and tubulin cytoskeletal reorganization processes, leading to the arrest 
of embryogenesis (Krens et al. 2008). Moreover it was demonstrated that ERK2 
is involved in synaptic plasticity, learning and memory (Long-Term Potentiation)  
(Adams & Sweatt 2002; Satoh et al 2007; Satoh et al 2011) and in regulating 
neuronal processes such as responses to growth factor and morphogens. 
(Biggs et al. 1994; Perron & Bixby 1999; Campbell & Holt 2001; Forcet et al 
2002; Ming et al 2002; Carrer et al  2003; Campbell & Holt 2003; Althini et al 
2004; Kim et al 2004; Pipet et al 2006). To further evaluate the possible 
contribution of ERK2 to the phenotype caused by miR-181a/b loss- and gain-of-
function, I decided to analyze its downstream targets in the signaling cascade 
involved in the modulation of  cytoskeletal regulator molecules. This signaling 
cascade, under the appropriate stimuli, lead to the activation of local protein 
synthesis of Cofilin/ADF (Actin Depolimerization Factor) and RhoA involved in 
actin retraction. As reported in figure 31, I found that miR-181a/b loss-of-
function, by increasing the ERK2 protein levels and ERK2 activity, increased the 
activation of this pathway. By western blot analysis I observed an increased 
phosphorylation of eiF4E, eiF4E-BP, and p70/S6K, markers of protein synthesis 
activation. Furthermore, I found that this activation led to increased levels of 
Cofilin and RhoA proteins (Fig. 31 A). To verify whether this increase in Cofilin 
production corresponded also to an increase in its activity, I evaluated the ratio 
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between its active form versus its inactive form. Cofilin protein is active in its de-
phosphorylated form and inactive when phosphorylated. I found that in 
morphant eyes the active form of Cofilin was increased (Fig. 31 C). Increase in 
Cofilin activation and RhoA levels have been already described to lead to 
growth cone collapse or turning (Campbell & Holt 2001; Lung et al. 2006; Piper 
et al. 2006; Campbell & Holt 2003). Therefore, their increased levels in miR-
181a/b morphant eyes could explain the axogenesis and axon length defects 
observed (Fig. 23 and 24).  
In overexpressing miR-181a/b embryos, I observed an opposite trend, with a 
general decrease of the MAPK-signaling cascade, that led to a reduction of 
Cofilin and RhoA protein levels, whose loss of activity on cytoskeletal 
reorganization could explain the severe developmental defects observed in the 
over-expressing embryos (Fig. 31 A). With these data I demonstrated that not 
only ERK2 is a real target of miR-181a/b, but also that its alteration mediated by 
miR-181a/b manipulation, had consequences on its downstream biochemical 
pathway. The alteration of this pathway could be underlying in the observed  
phenotypes. 
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3.11 Administration of the MEK inhibitor PD98059 rescues the IPL 
thickness phenotype of miR-181a/b morphant embryos 
If indeed the increase of ERK2 and of its downstream targets played a 
causative effect on the eye phenotype observed in miR-181a/b morphants, I 
hypothesized that by inducing their decrease I could obtain a rescue of that 
phenotype. Since it was not possible to down-regulate ERK2 by morpholino due 
to early embryonic lethality, as previously described, (Krens et al. 2008), I 
decided to adopt an alternative strategy based on the use of the drug PD98059. 
PD98059 leads to a decrease of ERK activation due to its selective inhibition of 
MEK1 and MEK2 kinase activity, responsible for ERK phosphorylation. 
Mo-miR-181a/b injected embryos were treated with hatching enzyme to remove 
the egg envelop and then were grown from stage 30 in the presence of the 
MEK inhibitor PD98059 at a concentration of 25 µM and 3%DMSO, used to 
facilitate the penetrance of the drug. As negative controls, we used control and 
morphant embryos treated with 3% DMSO only.  
The treatment with PD98059 was able to rescue the IPL defects of morphant 
eyes (Fig. 32 A a, b, c; red lines), quantified as the ratio between the IPL area 
and the total retina area (Fig. 32 B). By western blot experiments I found that 
this phenotypic rescue was accompanied by the rescue of the signaling 
pathway cascade alterations (Fig. 32 C, D). Consistent with my hypothesis, the 
levels of the total ERK2 protein did not change with respect to the untreated 
morphant embryos, and were persistently higher with respect to control 
embryos.  
Figure 32. The ERK2
phenotype (in vivo). 
miR-181a/b-morphants+PD98059(c) medaka
solution show that the MEKs inh
IPL phenotype (a-c, red line; and chart B). C
decrease the phospho
phonotype is due to the rescue of correct ERK
analysis  (D). 
To demonstrate that the rescue of the IPL thickness
accompanied by a rescue of the 
miR-181a/b-injected embryos with PD98059. I observed a signifi
amacrine processes formation, which was comparable 
controls (Fig. 33 C). These data allowed me to conc
phenotype is indeed caused by the loss of miR
as a consequence on its downstream targets, but als
role in amacrine cell axon specification via ERK2 m
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-Pathway alteration in miR-181-morphants retina causes IPL 
A) Frontal section of st40 of control (a), miR-181a/b
fish eye stainded with Richardson(Romeis) 
ibitor PD98059 added to miR-181a/b
-D) The PD98059 inhibiting the MEKs activity 
-ERK2 levels. (C) Western Blot demonstrate that the rescue of the 
-pathway activity, quantified by densitometric 
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axogenesis defects I treated the Six3.2 mo
with what present  in 
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-181a/b regulation on ERK2 and, 
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Figure 33. The PD98059 t
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of amacrine processes formation, indicating a miR
specification via ERK2 modulation.
The above in vivo analysis demonstrated that by decreasing the levels
ERK2 in morphant embryos I could obtain the rescue 
amacrine axogenesis defects. To demonstrate that th
cause also the RGC growth defects via ERK2, 
retina neurons in presence of the PD98059 drug
Ath5 transgenic line eye as previously described (s
I added PD98059 
analyzed the axon length of 100 mo
different experiments and different injections. I f
the MEKs inhibitor PD98059 on primary culture
rescued the axon leng
indicate that miR-181a/b play a role in RGC axon growth via ERK2 targ
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mo-miR-181a/b-injected embryos. Frontal cryostat sections of 
-miR-181a/b-injected (B) and mo-miR-181a/b
 embryos counterstained with DAPI (blue), showed 
-181a/b role in amacrine cell axon 
of the IPL phenotype and 
e loss of miR
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Figure 34. The PD98059 tratments rescue the RGCs axon length d
Medakafish Ganglion cell prim
181a/b-morphants+PD98059  (C) 
of the axon length defects as shown in the graph (D
3.12 TGF- on morphants embryos rescues the IP
The previous data  demonstrated that miR
modulate the MAPK signaling pathway. The miR
modulation  was needed to regulate the local protei
responsible for a correct axon specification and  a
To further investigate th
specification and growth 
study of the role of the 
through the modulation of RhoA levels, the axon spe
2010). Moreover, recent studies demonstrated 
biosynthesis of some miRNAs, including miR
2008; Hata et al. 2010; Wang 2010; Wang 2011).
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n synthesis activation 
xon growth. 
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extraction of TGF- (10ng/mL) treated eyes  compared to control eyes.
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ERK2 decrease and d
in vivo administration of TGF- (10ng/mL) increased
as assessed by TaqMan RT-PCR (Fig.
-181a and miR-181b was sufficient to lead to 
35 B) and ERK2 protein level decrease (Fig. 35 C).
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To further confirm my hypothesis, I administered TG
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Total ERK2 levels (Fig. 36 C, D), that finally led 
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Figure 36. in vivo administration of TGF
section of st40 of control (a), miR
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and RhoA levels, quantified by densitometric analysis  (D).
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4. DISCUSSION 
miRNAs appear to function as key regulators of biologically relevant molecular 
pathways through their ability to fine-tune gene dose (Zhao and  Srivastava, 
2007). Taking into account the fact that each miRNA can regulate the 
expression of several hundred target genes, the miRNA apparatus is expected 
to play a key role in controlling gene expression for a significant fraction of the 
vertebrate transcriptome. As a consequence, miRNAs are endowed with basic 
roles in the regulation of  development and pathophysiology of tissues and 
organs in vertebrates (see for some example the reviews Guller and Russell, 
2010; Bhatt, Mi and Dong, 2011; Bian and Sun, 2011; Im and Kenny, 2012).  
The general importance of miRNAs in eye development and diseases is 
supported by the effects observed in mice after conditional inactivation of Dicer, 
a key enzyme in miRNAs biogenesis (Damiani et al. 2008; Georgi et al. 2010; 
Iida et al. 2011; Pinter et al. 2010). However, there is still little information 
available on the specific role of individual miRNAs contributing to the correct 
development and function of the eye. Genetic gain- and loss-of-function studies 
performed in frogs, fish, and mice are beginning to disclose the role of specific 
miRNAs in retinal development, physiology and disease (see for a review 
Sundermeier and Palczewski, 2012). These studies suggested that the role and 
composition of miRNA-regulated gene network in eye development is wide and 
is only starting to be unravelled. 
The aim of my project was to identify miRNAs highly enriched in the vertebrate 
eye and to investigate their roles in the regulatory networks underlying eye 
developmental processes. To study individual microRNA functions, I took 
advantage of Medakafish (Oryzias latipes), which is considered an ideal model 
organism to study developmental biology processes including eye development 
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(Wittbrodt et al., 2002). Indeed, medakafish is a model system particularly 
amenable for reverse-genetic analyses. Microinjections of either mimic or 
antisense morpholino oligonucleotides results, respectively,  in gene/miRNA 
overexpression or knockdown, without any laborious, time- and resource- 
consuming techniques (Ishikawa, 2000), as already demonstrated in recent 
work published in Banfi’s lab (Conte et al. 2010a).  
Starting from microRNA microarray profiling analysis, I first identified a group of 
evolutionarily conserved eye-enriched microRNAs (Fig. 17). Among them, I 
focused my attention on the functional characterization of the miR-181a/b 
cluster. I demonstrated that, besides their sequence, also their expression 
profile during eye development is highly conserved across vertebrate evolution 
(Fig. 18 and 19). The combined down-regulation of miR-181a and miR-181b, by 
morpholinos, caused a specific retinal phenotype characterized by the reduction 
of the Inner Plexiform Layer (IPL) thickness (Fig. 21), without any apparent 
reduction in the number of retinal cells (Fig. 22). Taking advantages of the 
availability of specific medakafish transgenic lines, I demonstrated that miR-
181a/b loss-of-function led to defect of axogenesis in amacrine and retinal 
ganglion cells (RGCs) (Fig. 23).  
By means of in silico predictions and using a variety of in vitro and in vivo
experimental approaches, I have shown that ERK2 is a target of miR-181a/b 
activities (Fig. 29). I also demonstrated that the specific miR-181–mediated 
regulation of ERK2 modulates the function of the MAPK signaling cascade, 
which is  involved in axon growth control (Fig. 37). These data indicate that 
miR-181a/b are essential component of the MAPK  molecular pathway, and 
hence are important element of the molecular network that regulates axon 
formation during amacrine cell and RGC  development.  
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The ERK, p38, JNK mitogen-activated protein kinases (MAPKs) are intracellular 
signaling pathways that play a pivotal role in many essential cellular processes, 
such as proliferation and differentiation (see for a review Kyriakis and Avruch, 
2012). The extracellular signal-regulated kinases (ERK1/2) are among the most 
prominent signal transduction molecules through which extracellular stimuli are 
propagated from the cell surface to cytoplasmic and nuclear effectors. ERK1 
(mapk3) and ERK2 (mapk1) exhibit 84% sequence identity and are activated 
through the sequential phosphorylation of the mitogen-activated protein kinase 
(MAPK) cascade. Significantly, although both ERK1 and ERK2 are expressed in 
the same tissues (Selcher et al., 2001; Mazzucchelli et al., 2002), genetic 
inactivation of ERK1 has only subtle phenotypic effects, whereas ERK2 
inactivation results in early embryonic lethality (Aouadi et al., 2006). These 
studies strongly support our hypothesis of a regulatory cascade in which miR-
181a/b are required to modulate the MAPK signaling pathway. Indeed, miR-
181a/b over-expression led to a significant down-regulation of ERK2 activity, 
with phenotypic consequences similar to those observed after ERK2 loss-of-
function, in both murine and fish models (Fig. 26). Krens and colleagues, in 
2008, demonstrated that mo-erk2 zebrafish embryos display severe 
developmental defects due to primary changes in gastrulation cell movements 
and not caused by altered cell fate specification. Their data demonstrated that 
the absence of phospho-ERK2 from the blastula margin blocked initiation of 
epiboly, actin and tubulin cytoskeleton reorganization processes and further 
arrested embryogenesis (Krens et al.2008). Similar to mouse, also in zebrafish 
ERK1 knockdown had only a mild effect on epiboly progression, defining distinct 
roles for ERK1 and ERK2 in developmental cell migration processes during 
embryogenesis. In our miR-181 over-expressing medakafish embryos, I 
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demonstrated that the decrease of ERK2 levels led to decreased Cofilin/ADF 
and RhoA protein levels, impairing actin remodeling and consequently leading 
to severe developmental defects. 
To determine the role of ERK2 during nervous system development, a  murine 
model in which mapk1/ERK2 undergoes conditional inactivation at the peak of 
neurogenesis was previously generated, allowing the identification of ERK2 
involvement in synaptic plasticity, learning and memory (Adams & Sweatt 2002; 
Satoh et al 2007; Samuels 2008; Satoh et al 2011). It has been recently 
demonstrated that a group of genetic disorders termed neuro-cardio-facial 
cutaneous syndromes (including cardio-facio-cutaneous, Costello, Leopard, and 
Noonan syndromes) are caused by mutations in upstream elements of the 
ERK/MAPK signaling cascade (Bentires-Alj et al., 2006; Roberts et al., 2006) 
and are generally characterized by distinctive cardiac and craniofacial defects, 
developmental delay, and mental retardation. The mutation of downstream 
elements in the ERK cascade has similarly been associated with mental 
retardation syndromes (Weeber and Sweatt, 2002). The identification of 
individuals with haploinsufficiency for the ERK2 gene as a result of distal 
microdeletions at 22q11.2 (Shaikh et al., 2007) enabled the first analysis of 
humans with reduced expression levels of ERK2. These patients exhibit 
microcephaly and neurodevelopmental deficits, consistent with the phenotype 
observed in the murine models.  
During nervous system development, the ERK/MAPK signaling is activated in 
responses to growth factor and morphogens involved in neuronal processes 
formation (Biggs et al. 1994; Perron & Bixby 1999; Campbell & Holt 2001; 
Forcet et al 2002; Ming et al 2002; Carrer et al  2003; Campbell & Holt 2003; 
Althini et al 2004; Kim et al 2004; Pipet et al 2006). The in vitro stimulation of 
112 
ERK/MAPK signaling activity, through the use of repulsive guidance cues such 
as SEMA3A and/or Slit2, led to growth cone collapse or turning and inhibition of 
neurite growth (Campbell & Holt 2003; Piper et al. 2006). This inhibition is due 
to the Cofilin/ADF and RhoA protein synthesis, via phosphorylation of eiF4E 
and mTOR pathway activation (Campbell & Holt 2001; Lung et al. 2006; Piper 
et al. 2006; Campbell & Holt 2003). These observations suggest that 
perturbations in ERK/MAPK signaling, in both positive or negative directions, 
underlie a diverse range of neurodevelopmental defects.  
In agreement with these data, in medakafish embryos, expression levels of 
ERK2 and, concomitantly, the activation of its downstream targets (Fig. 31) are 
increased in miR-181a/b knock-down eyes. Furthermore, the axon growth 
alterations observed in miR-181a/b morphants (Fig. 24) strongly resembled 
those reported for ERK2 activation in Xenopus axon growth cone upon 
repulsive cues stimulation (Campbell & Holt 2003). 
I found that concomitant knockdown of miR-181a/b and decrease of ERK2 
phosphorylation, using PD98059, significantly rescued levels of phospho-ERK2 
and its downstream targets, phospho-eiF4E, phospho-eiF4E-BP, phospho-p70, 
Cofilin and RhoA levels in the eyes (Fig. 32), leading to the rescue of axon 
defects (Fig. 33 and 34). The above observations are consistent with a pathway 
in which miR-181a/b control local protein synthesis activation and axon growth 
through regulation of ERK2 levels. In summary, these data demonstrated, at 
least in RGCs, that miR-181a/b play an important role in axon growth via ERK2 
modulation, and that the loss of their functions caused a decrease in axon 
length. The in vitro primary culture experiments (Fig. 24 and 34) gave also the 
indication that these axon defects are RGC cell-autonomous and did not 
depend on altered information that could derive from surrounding tissues. 
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Additional  experiments are needed to determine if the branching defects of 
RGCs axons at optic tectum are secondary effects due to these axon growth 
defects or are due to the loss of miR-181a/b function in the optic tectum 
neurons. Using the cell transplantation technique it will be possible to isolate the 
eye precursor cells or optic tectum precursor cells from mo-miR-181s-injected 
embryos and transplant them in a control embryos. In that way, it will be 
possible to discriminate between the defects due to the miR-181s ablation in the 
retina cells and the defects due to the miR-181s ablation in the optic tectum.  
The experiment carried out in the Six3.2:eGFP transgenic line (Fig. 23) 
highlighted another axonal phenotype characterized by the presence of different 
processes emerging from a single amacrine cell body, instead of one specified 
axon as in controls. One explanation for this phenotype could be that the miR-
181a/b loss-of-function led not only to RGC axonal defects but, during amacrine 
cells development, also caused the trans-differentiation of one amacrine 
subtype to another. Indeed there is a strong variability in the amacrine structure 
of the different and numerous amacrine subtypes. However, the first analysis of 
amacrine cell markers to identify the different subtype, did not highlight an 
increased number of one subtype at the expense of others. The use of 
additional other markers will be helpful to complete this analysis. However, the 
other and more likely explanation would be that the different processes, 
observed in mo-miR-181a/b Six3.2:eGFP amacrine cells, correspond to multiple 
specified axons or immature processes that are not correctly specified in axon 
or dendrites. Dotti and colleagues demonstrated that the axon specification 
process starts with neuronal polarization that occurs when one of the neurites 
emerging from the cell body elongates rapidly; this neurite becomes the axon, 
whereas the remaining neurites become dendrites (Dotti et al. 1988). In 1999, 
114 
Bradke and  Dotti also demonstrated that the neurite with the most active 
growth cone became the cell’s axon (Bradke and Dotti, 1999). Furthermore, 
they showed that inactivation of RhoA produced the loss of F-actin and the 
growth of multiple axons, concluding that the remodelling of growth cone actin is 
a physiological requirement for neuronal polarization and that the Rho family of 
GTPases is involved in the control of neuronal polarization (Bradke and Dotti, 
1999). 
In the mo-miR-181a/b-injected eyes, I observed the increase of RhoA levels 
and Cofilin/ADF, as final result of the increased activation of the MAPK 
signaling cascade. Supported by the rescue experiments in both in vitro and in 
vivo conditions, I demonstrated that the ERK2 increased activity is the cause of 
the axon growth defects in RGCs, and the axon specification defects of 
amacrine cells (Fig. 33 and 34). The physiological down-regulation of RhoA, 
needed for neuron polarization and rapid elongation of one neurite, did not 
occur in amacrine cells following miR-181a/b function ablation. This could 
explain why, even if partially polarized, amacrine cells of miR-181a/b morphant 
embryos did not correctly specify the axon. With the in vitro analysis of 
medakafish RGCs primary cultures, it was not possible to further investigate this 
axon specification phenotype because the in vitro cultured RGCs  have the 
ability to polarize intrinsically, with the immediate and fast growth of one 
extension that becomes the principal axon (Zolessi et al. 2006). The presence 
of two different phenotype for RGCs and amacrine cells could be explained 
analyzing the onset of miR-181s expression (Fig. 19). Indeed miR-181a/b 
started to be detected by ISH at stage 30 when the RGCs have already 
specified their axons whereas the amacrine cells are differentiating and do not 
have yet specified the axons. This implicated a RGC axon specification 
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mechanism independent from the miR-181a/b activity, whereas their functions 
are needed in the other phases of RGC axon growth. The presence of a 
different mechanism for axon specification in the RGCs is in agreement with 
previous in vivo data which report that the developing RGC axons emerge 
directly from uniformly polarized cells in the absence of other neurites (Zolessi 
et al. 2006).   
On the contrary, in amacrine cells, the loss of miR-181a/b function in a pre-
axon-specification stage determined firstly an axon specification defect. To 
further investigate and elaborate these observations, I will determine the best in 
vitro culture condition to analyze amacrine axon formation in control and 
morphant eye explants. I will use a medakafish transgenic line in which the GFP 
is expressed under the control of an amacrine-specific promoter, such as the 
Six6 promoter. In in vitro condition it will be possible to use axon specific marker 
(Tau1), and/or dendrites specific marker (Map2), in order to determine if the 
multiple observed processes are multiple specified axons (Tau1 positive), 
dendrites (MAP2 positive) or unspecified processes.  
As previously mentioned, Bradke and Dotti identified a mechanism by which the 
neurite with the most active actin filament dynamics becomes the axon, and that 
the RhoA GTPase is implicated in this mechanism. Moreover they hypothesized 
that the selection of the neurite to become axon depends on the contact with a 
factor, or different concentration of it, that activate a signaling cascade leading 
finally to actin remodeling and process elongation. Only recently it was 
demonstrated that, at least in the brain, this signaling cascade is mediated by 
the TGF- molecules (Yi et al. 2010). In this study, the authors demonstrated 
that the TGF--dependent axon specification in brain is a Smad- independent 
mechanism, mediated by site specific phosphorylation of Par6. The latter,  by 
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recruiting the ubiquitin ligase Smurf1, promotes the proteasomal degradation of 
RhoA (Ozdamar et al. 2005). In their model, in the neurite nearest the TGF-
gradient area, the local levels of RhoA result to be decreased and altered the 
actin dynamics, allowing the process elongation and axon specification. 
At present, a similar mechanism is not yet described for the retinal amacrine 
cells axon specification. To further investigate on the regulatory network 
involved in amacrine axon specification via miR-181a/b, I decided to focus my 
attention on the TGF- pathway.   
Different studies, reported in literature, identified an antagonistic effect between 
the TGF-/BMP pathways and ERK2 in the regulation of axon/dendrites 
specification and growth (Kerrinson et al. 2005; Hocking at al. 2007; Walshe et 
al. 2011; Kim et al. 2004). In these studies the authors demonstrated that 
members of BMP family increase neurite number, length and complexity 
(Kerrinson et al.2005). Developing similar analysis on retinal neurons, Hocking 
et al, from McFarlane group,  addressed the role of TGF- ligands in promoting 
RGC dendrites in vivo and in vitro (Hocking et al. 2007). Interestingly in the 
study of Walshe and colleagues, a crosstalk between TGF- and the MAPK 
signaling was identified in the RGC-5 cell line (Walshe et al. 2011).  Kim and 
colleagues analyzed the crosstalk between TGF-/BMP and ERK/MAPK 
pathways in in vitro rat sympathetic neurons, demonstrating that inhibition of 
ERK1/2 functions potentiates dendritic versus axonal growth in the presence of 
BMPs, whereas its FGF-mediated activation inhibits the TGF-/BMP-stimulated 
dendritic growth in sympathetic neurons (Kim et al. 2004).  
Even if a conspicuous  number of studies indicated that these two signaling 
pathways act in an antagonistic manner in the neuronal processes formation, it 
was not yet identified the molecular mechanism through which this antagonism 
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was exerted. I investigated about a possible role for TGF- in the regulation of 
retina axon specification, hypothesizing two different mechanism: the first, as in 
the brain, consisting in the activation of Par6 and subsequent decrease of RhoA 
due to its ubiquitination and degradation (Yi et al. 2010); the second, through 
the increase of miR-181a/b maturation (Davis et al. 2008; Hata et al. 2010), 
subsequent ERK2 decrease and decreased protein synthesis of RhoA. This 
hypothesized mechanism is represented in figure 37, in the schematic model for 
miR-181a/b action in neuronal process formation. My data demonstrated that in 
vivo administration of TGF- caused an increase of miR-181a and miR-181b 
mature levels in the medakafish eye, and that this increase was sufficient to 
lead to ERK2 decrease, at both transcript and protein levels (Fig. 35). The 
possible role of TGF- in retinal axon specification and growth, exerted via miR-
181a/b, was validated through the rescue of IPL defects obtained upon TGF-
administration on morphant embryos (Fig. 36 A, B). The reduction of the Total-
ERK2 levels indicated that this rescue may be due, at least in part, to the action 
of TGF- on miR-181a/b levels, which by modulating the ERK2 levels, finally led 
to the decrease of RhoA protein levels (Fig. 36 C, D). Further experiments, 
using the proteasomal inhibitor MG132, will be necessary in order to determine 
the amount of RhoA decrease due to the decrease of its protein synthesis, via 
miR-181a/b-mediated modulation of the MAPK cascade, rather than to its 
degradation, via Par6 induced proteasomal degradation (Fig. 37). With these 
experiment I will be able to discriminate the relative contribution of the two TGF-
-mediated mechanism in the regulation of RhoA levels and axon specification 
in the retina.    
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4.1 Conclusions 
I begun the functional characterization of miRNAs with a role in eye 
development by first using a high-resolution expression screening to identify 
those with the most significant expression levels in the vertebrate eye. Among 
them, the functional characterization of miR-204 and of the miR-181a/b cluster 
gave important results, with a strong impact on the knowledge of the miRNA 
regulatory networks underlying the vertebrate eye development. The analysis of 
miR-181a/b ablated medakafish embryos revaled the role of these two miRNAs 
in the axon specification and growth of amacrine and ganglion cell axons. The 
morphological retinal axon defects in miR-181a/b- ablated embryos, led to 
impaired retinal circuits assembly responsible of visual function defects. I 
demonstrated that the functions of miR-181a/b during eye development are 
largely mediated by ERK2 targeting and by the modulation of its downstream 
signaling cascade involved in the growth cone cytoskeleton remodeling. For the 
first time I provide in vivo evidences of an antagonism between the TGF-
pathway and the ERK2 cascade in the regulation of retina axon specification 
and growth. My data demonstrated that this antagonism is exerted via miR-
181a/b activity regulation. The TGF--activated miR-181a/b, targeting ERK2
and modulating the MAPK cascade, play a key role in the signaling network that 
define the correct axon specification and growth needed  for the development 
and the assembly of a functional retina neural circuits. 
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miR-204 is required for lens and retinal development via Meis2 targeting 
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regulation of gene expression. The roles of individual miRNAs in controlling vertebrate 
eye development remain, however, largely unexplored. Here, we show that a single 
miRNA, miR-204, regulates multiple aspects of eye development in the medaka fish 
(Oryzias latipes). Morpholino-mediated ablation of miR-204 expression resulted in an 
eye phenotype characterized by microphthalmia, abnormal lens formation, and altered 
dorsoventral (D-V) patterning of the retina, which is associated with optic fissure 
coloboma. Using a variety of in vivo and in vitro approaches, we identified the 
transcription factor Meis2 as one of the main targets of miR-204 function. We show 
that, together with altered regulation of the Pax6 pathway, the abnormally elevated 
levels of Meis2 resulting from miR-204 inactivation are largely responsible for the 
observed phenotype. These data provide an example of how a specific miRNA can 
regulate multiple events in eye formation; at the same time, they uncover an as yet 
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MicroRNAs (miRNAs) are small noncoding RNAs that have impor-
tant roles in the regulation of gene expression. The roles of indi-
vidual miRNAs in controlling vertebrate eye development remain,
however, largely unexplored. Here, we show that a single miRNA,
miR-204, regulates multiple aspects of eye development in the
medaka ﬁsh (Oryzias latipes). Morpholino-mediated ablation of
miR-204 expression resulted in an eye phenotype characterized
by microphthalmia, abnormal lens formation, and altered dorso-
ventral (D-V) patterning of the retina,which is associatedwith optic
ﬁssure coloboma. Using a variety of in vivo and in vitro approaches,
we identiﬁed the transcription factor Meis2 as one of the main
targets of miR-204 function. We show that, together with altered
regulation of the Pax6 pathway, the abnormally elevated levels of
Meis2 resulting from miR-204 inactivation are largely responsible
for the observed phenotype. These data provide an example of
how a speciﬁc miRNA can regulate multiple events in eye forma-
tion; at the same time, they uncover an as yet unreported function
of Meis2 in the speciﬁcation of D-V patterning of the retina.
microRNA | eye development | medaka ﬁsh
Development of the vertebrate eye takes place through a seriesof morphogenetic events that are controlled by molecular
networks in which transcription factors and signaling pathways
have major roles (1). Speciﬁc components of these networks are
reiteratively exploited in space and time to pattern eye tissues and
to control the subsequent cellular programs, such as cell pro-
liferation, differentiation, migration, and programmed cell death
(2, 3). Most of these developmental processes are critically sen-
sitive to gene dose, and variations in the normal levels of regu-
latory proteins appear to result in a variety of eye anomalies (4, 5).
Posttranscriptional regulatory mechanisms maintain the appro-
priate levels of expression of these proteins and enable rapid
changes in the cellular proteome; thus, they have fundamental
roles in the development of the nervous system (6).
MicroRNAs (miRNAs) are a class of 20- to 25-nucleotide
noncoding RNAmolecules that mediate a newly recognized level
of posttranscriptional control of gene expression. Indeed, miR-
NAs can impair either mRNA translation or stability by binding
through imperfect base pairing to speciﬁc sites in the 3′-UTR of
target mRNAs (7). Recently, many miRNAs have been shown to
be required for vertebrate developmental processes, such as cell
fate determination and patterning as well as cell death and pro-
liferation (8).
A number of miRNAs show restricted expression patterns in
the developing lens, retinal pigment epithelium (RPE), neural
retina, and other ocular tissues, which suggests their potential
relevance to eye development and function (9, 10). However, the
precise roles of individual miRNAs and their speciﬁc inﬂuences
on given mRNA targets that are important for vertebrate eye
development remain unclear.
In the present study, we show that miR-204, which is highly
expressed in the presumptive RPE, lens, ciliary body, and neural
retina (11, 12), is required for correct lens and optic cup de-
velopment. Using a variety of gain- and loss-of-function ap-
proaches in the medaka ﬁsh [Oryzias latipes (ol)], we demonstrate
that miR-204–mediated modulation of the Meis2 gene dose has
a signiﬁcant impact on regulation of the genetic pathways con-
trolling eye morphogenesis and differentiation.
Results
miR-204 Knockdown Causes Lens Abnormalities, Microphthalmia, and
Eye Coloboma. We found that during early medaka development
[stage (St) 23], ol-miR-204 was expressed in the lens placode and
in the presumptive RPE, with an apparent dorsalhigh-to-ventrallow
gradient (Fig. S1A). At later stages, ol-miR-204 expression was
also detected in the ciliary marginal zone, ciliary body, and pre-
sumed migratory neural crest cells (Fig. 1 A–A′). This expression
pattern suggested that miR-204 might modulate different aspects
of eye development.
To investigate this further, we interfered with miR-204 pro-
cessing and activity using a multiblocking morpholino (Mo)-based
knockdown approach (13). To this end, we designed twoMos,Mo-
miR-204- and Mo-miR-204-2, against the two ol-miR-204-1 and
ol-miR-204-2 precursor sequences present in the medaka genome,
which give rise to an identical maturemiR-204 sequence. Embryos
injected with either of these two Mos at the one-cell stage were
morphologically indistinguishable from control embryos up to the
optic-vesicle stage. In contrast, from St24 onward, an aberrant eye
phenotype was clearly visible in most of the Mo-miR-204–injected
embryos (65 ± 5% of 3,000 injected embryos). Growth of the eye
cup was signiﬁcantly impaired and culminated in evident micro-
phthalmia at St40 (Fig. S2A andD). In 90%of themicrophthalmic
embryos, lens development was also impaired. Speciﬁcally, at St24,
the monolayer of lens epithelial cells was positioned in the dorsal
region of the lens vesicle instead of lining its distal surface in mor-
phants (Fig. 2 A–F, Fig. S3 H, H’, J, and J’, and Fig. S4 A, B, G,
and H). Furthermore, the primary ﬁber cells that are located in
the center of the lens vesicle were misplaced and disorganized,
whereas those of the control embryos had begun to elongate to form
the organized concentrical layers (Fig. 2 A–F and Fig. S4 A, B, G,
and H). This altered cellular organization was also evident at later
stages, when abnormal ventral-distal herniations of the lens were
also evident (Fig. S2E). Finally, a signiﬁcant number of the micro-
phthalmicmorphant embryos (30%)were characterized by a ventral
coloboma, through failure of optic ﬁssure closure (Fig. S2C and F).
We did not observe any qualitative and quantitative pheno-
typic differences following the injection of Mo-miR-204-1 or Mo-
miR-204-2; hence, subsequent studies were performed only with
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Mo-miR-204-1. The Mo blocking efﬁciency and the speciﬁcity
of the eye phenotype were veriﬁed through a series of experiments
described in SI Text (Fig. S1 and Tables S1 and S2). These in-
cluded RNA in situ hybridization (ISH) using the miR-204-locked
nucleic acid antisense probe and injections of 6-bp–mismatched
Mo (mm-Mo-miR-204), which gave no aberrant phenotype at any
concentration (Table S2). To rule out off-targeting Mo effects, we
coinjected Mo-miR-204-1 and a Mo against p53 (Mo-p53). We
did not observe any modiﬁcations of the phenotype, which further
conﬁrmed the speciﬁcity of Mo-miR-204 targeting (14) (SI Text
and Fig. S2 V–X).
Meis2 Gene Is a Direct Target of miR-204. Given the speciﬁcity of
this miR-204 loss-of-function phenotype, we searched for its
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Fig. 1. miR-204 directly targets Meis2. (A–C′) Frontal sections of St24 WT
medaka embryos hybridized in both single (A–B′) and double (C and C′)
whole-mount RNA ISH with probes against olMeis2 (red) and miR-204 (blue).
miR-204 (A and A′) and olMeis2 (blue) (B–B′) colocalize in the lens placode and
ciliary marginal zone (C–C′). Boxed areas are magniﬁed inA′–C′. (D) Predicted
target site ofmiR-204within the 3′-UTR of theMeis2gene in different species,
showing conserved nucleotides (red) and nonconserved nucleotides (black).
The blue line represents the sequence against which Meis2-TPmiR-204 Mo
was designed. (E) Relative Luc activities in H36CE cells as fold differences in
the Luc/Renilla ratios normalized to the value of Luc reporter constructs. miR-
204 addition signiﬁcantly decreases Luc activity of the construct containing
3′-UTR ofMEIS2 when compared with controls. ***P < 0.0001 (t tests). Three
point mutations in the predicted miR-204 target site in Meis2 inhibit this ef-
fect (no signiﬁcant variation when compared with the thymidine kinase (TK)-
Luc control). Densitometric analysis (F) of Western blotting (G) shows
reduction of Meis2 protein levels in the presence of miR-204 duplexes and
increase after miR-204 depletion when compared with cel-miR-67 control
transfections. **P < 0.001; ***P < 0.0001 (t tests). 1, inhibitor hsa-miR-204; 2,
inhibitor cel-miR-67; 3, mimic hsa-miR-204; 4, mimic cel-miR-67. Relative levels
of the Meis2 protein measured 48 h after transfection of H36CE cells. (H–M)
Frontal sections of St24 control (H and K), miR-204–overexpressing (I and L),
and Mo-miR-204–injected (J and M) embryos treated for whole-mount RNA
ISH with an olMeis2 probe (H–J) or immunostained with an anti-Meis2 anti-
body (green) (K–M). Sections are counterstained with propidium iodide (PI,
red). Both olMeis2mRNAandprotein are down-regulated in lens placode and
retina of miR-204–overexpressing embryos (I and L) but up-regulated in miR-
204 morphants (J andM). (Scale bars: 20 μm.).
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Fig. 2. Interference with miR-204 expression modiﬁes lens cell differentia-
tion via Meis2 targeting. Frontal sections of St24 control (A–C), Mo-miR-204
(D–F), miR-204 (G–I), Mo-Meis2/Mo-miR-204 (J–L), Meis2-TPmiR-204 (M–O),
and Meis2-TPmiR-204/miR-204 (P–R)–injected medaka embryos processed for
whole-mount RNA ISH with probes speciﬁc for olMeis2 (A, D, G, J,M, and P),
olPax6 (B, E,H, K,N, andQ), and olα-ACrystallin (C, F, I, L,O, and R). Expression
of olMeis2 (D andM) and olPax6 (E and N) is up-regulated in lens of miR-204
and Meis2-TPmiR-204 morphant embryos, whereas that of olα-ACrystallin is
increased in the lens placode and ectopically expressed in the epithelial lens
monolayer (F and O, yellow arrowheads). Lens epithelial (D–F and J–L, red
arrowheads) and primary ﬁber (D–F and J–L, black arrowheads) cells are dis-
placed. (J) MOs act at the translational level; thus, Mo-Meis2/Mo-miR-204
coinjection does not rescue olMeis2 mRNA expression. miR-204 gain-of-
function has opposite effects in lens gene expression, without affecting lens
epithelial monolayer (G–I, red arrowheads) and the primary ﬁbers (G–I, black
arrowheads). Mo-Meis2/Mo-miR-204 and Meis2-TPmiR-204/miR-204 coin-
jections restore correct expression of lens differentiation markers (J–L and
P–R). Mo-Meis2/Mo-miR-204 coinjections do not rescue cell displacement (J–L,
red and black arrowheads). Broken lines mark boundaries between the lens
epithelial monolayer and the primary ﬁber cells. (Scale bars: 20 μm.)
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potential mRNA targets using the recently developed host-gene
oppositely correlated target (HOCTAR) tool, which integrates
expression proﬁling and sequence-based miRNA target recog-
nition software (15). Among the predicted miR-204 targets, the
homeobox transcription factors Meis1 and Meis2 appeared par-
ticularly attractive to explain the observed eye defects because
they had been previously shown to regulate vertebrate eye de-
velopment by modulating Pax6 expression (16). Furthermore,
the predicted target site of miR-204 within the 3′-UTR of Meis2
(but not of Meis1) was highly conserved across all vertebrate
species analyzed, including medaka (Fig. 1D). To validate this
prediction, we cloned the 3′-UTR of the human MEIS2 gene
containing the miR-204 target site downstream of the coding
region of the Luciferase (Luc) reporter gene, and tested the
ability of miR-204 to affect reporter expression in vitro. The
presence of the MEIS2 3′-UTR sequence speciﬁcally inhibited
Luc activity in response to miR-204 (Fig. 1E). In addition, point
mutations in the miR-204 binding site of the MEIS2 3′-UTR
abolished this repression, indicating that miR-204 directly and
speciﬁcally targets MEIS2 (Fig. 1E). In agreement with these
observations, the levels of MEIS2 protein in H36CE human lens
epithelial cells were decreased in the presence of miR-204
duplexes and elevated on miR-204 inhibition (Fig. 1 F and G).
The speciﬁcity of this repression was conﬁrmed by additional
controls described in SI Text (i.e., a Luc construct containing the
3′-UTR of PAX6 and miR-182, an unrelated miRNA expressed
in the eye) (Fig. S3 K–N).
The miR-204 targeting of Meis2 was also conﬁrmed in vivo.
miR-204 and Meis2 showed overlapping expression patterns in
the lens and in the peripheral optic cup (Fig. 1 A–C′). Moreover,
injections of miR-204 duplexes resulted in a decrease in en-
dogenous Meis2 mRNA and protein levels, whereas injections of
Mo-miR-204 led to an increase in the optic cup of medaka
embryos (Fig. 1 H–M). The expansion of theMeis2 domain in the
miR-204 morphants was not caused by a generalized delay of eye
development because (i) Meis2 was correctly expressed at early
stages of lens and retinal development in the morphants (Fig. S3
G–J′) and (ii) Ath5, an early marker of retinal ganglion cell
differentiation, was expressed normally at St26, when the retina
begins to differentiate (Fig. S3 O and P). Altogether, these data
strongly indicate that Meis2 is a bona ﬁde miR-204 target.
miR-204 Controls Lens Differentiation by Targeting Meis2 and
Modulating the Pax6 Transcriptional Pathway. We next sought to
determine whether the miR-204 morphant phenotype was in-
deed related to abnormal activation of olMeis2 expression. Meis2
has been reported to regulate Pax6 activity in the lens in a direct
and positive way (16). Pax6, in turn, controls the expression of
genes involved in lens differentiation, including Sox2, Prox1, and
α-ACrystallin (17, 18). With the exception ofMeis2, none of these
genes are predicted to contain miR-204 target sites. We thus
reasoned that if miR-204 directly controls expression of Meis2 in
vivo, the levels of expression of all these genes should be in-
creased in the miR-204 morphant as a consequence of alter-
ations in Meis2 expression.
Indeed, RNA ISHdemonstrated that in themorphant optic cup,
olPax6, olSox2, olProx1, and olα-ACrystallin showed up-regulated
expression and/or were misexpressed in both lens ectoderm and
primary lens ﬁber cells when compared with control embryos (Fig.
2 A–F and Fig. S4 A, B, G, and H). To demonstrate a direct in-
teraction between miR-204 and Meis2 further, and to dissect out
the role of this interaction in lens development, we increased the
levels of miR-204 by injecting miR-204 duplexes. From St20 on-
ward, duplex-injected embryos were severely microphthalmic, with
small lenses (Fig. S2 J–L), which strongly resembled the phenotype
reported forMeis2.2 zebraﬁsh morphant embryos (19). Consistent
with the hypothesis that olMeis2 is an important miR-204 tar-
get, expression of the olMeis2, olPax6, olSox2, olProx1, and olα-
ACrystallin genes was signiﬁcantly reduced in the lens placode of
all the duplex-injected embryos (Fig. 2G–I and Fig. S4C and I), as
conﬁrmed by quantitative real-time qRT (PCR) (Fig. S4M). Of
note, inhibition of miR-204 activity by Mo-miR-204 injections was
accompanied by an opposite trend in the relative transcript levels
(Fig. S4N). Interestingly, both the lens epithelial monolayer and
the primary ﬁber cells were normally localized in duplex-injected
embryos (Fig. 2 G–I and Fig. S4 C and I).
If most of the changes in lens differentiation marker expression
caused by miR-204 knockdown are mediated byMeis2, coinjection
of a Mo against olMeis2 (Mo-Meis2) should reestablish normal
expression levels in miR-204 morphants. Consistent with this, Mo-
Meis2 injection was sufﬁcient to rescue the normal expression of
lens differentiationmarkers in a substantial proportion ofmiR-204
morphants (Fig. 2 J–L, Fig. S4 D and J, and Table S2), although
defects in epithelial and lens ﬁber cell organization were not res-
cued (Fig. 2 J–L and Fig. S4 D and J). This suggests that miR-204
regulates additional, and as yet unidentiﬁed, genes that are im-
portant for correct lens development.
To obtain additional support for the importance of miR-204–
mediated regulation of olMeis2, we disrupted the interaction of
miR-204 with its target site in olMeis2 3′-UTR by injecting aMeis2
“target protector” (20)Mo (Meis2-TPmiR-204) inWTembryos (SI
Text and Fig. S3 A–F). A signiﬁcant percentage of Meis2-TPmiR-
204–injected embryos weremorphologically indistinguishable from
miR-204morphants and characterized by similar defects in the lens,
optic cup size, and optic ﬁssure coloboma (Fig. S2 G–I and Table
S2). Moreover, protection of the miR-204 target site within Meis2
mRNA resulted in expansion of the lens placode expression
domains of olMeis2, olPax6, and olSox2 and mislocalization of
olProx1 and olα-ACrystallin, the mRNAs of which were ectopically
detected in the epithelial cell monolayer (Fig. 2M–O and Fig. S4E
and K). Unlike our observations in miR-204 morphant embryos,
these changeswere not associatedwith defects in epithelial and lens
ﬁber cell organization (Fig. 2 M–O and Fig. S4 E and K), further
supporting the possibility that these alterations are mediated by
other mRNA targets. Finally, protection of Meis2 targeting was
sufﬁcient to rescue the correct expression of lens differentiation
markers in miR-204–overexpressing embryos (Fig. 2 P–R and Fig.
S4 F and L).
Altogether, these data indicate that miR-204 controls lens cell
differentiation by modulating the expression of lens placode
differentiation genes via the Meis2/Pax6 pathway.
miR-204 Has an Active Role in Establishment of Dorsoventral Polarity
of the Optic Cup. Defects in optic ﬁssure closure were observed in
both the Mo-miR-204 and Meis2-TPmiR-204 morphants (Fig. S2
D–I). Colobomas have been frequently described as a conse-
quence of impaired dorsoventral (D-V) polarity of the optic cup
(21). As observed in the lens, this defect was associated with
concomitant up-regulation of olMeis2 (Fig. 1 H, J, K, and M and
Fig. S5B) and olPax6 expression. In particular, olPax6 expression
extended to the ventral retina, where it is normally expressed at
relatively low levels (Fig. 3 A, D, and M). Previous studies have
shown that expansion of Pax6 expression in the ventral retina
results in alterations in D-V polarity of the optic cup (22, 23).
Therefore, we askedwhether expression ofD-V optic cupmarkers
was modiﬁed in Mo-miR-204 and Meis2-TPmiR-204 morphants.
In all the injected embryos, the expression domain of the ventral
marker olVax2 and the ventral expression domain of olPax2 (24)
were reduced or absent (Fig. 3 B, E, and N and Fig. S5 E and H),
whereas the expression domains of the dorsal markers olBmp4
and olTbx5 were ventrally expanded (Fig. 3 C, F, and O and Fig.
S5 K and N). A reciprocal molecular phenotype was observed
after miR-204 overexpression: The olBmp4 and olTbx5 domains
were largely reduced, whereas those of olPax2 and olVax2 were
dorsally expanded (Fig. 3 H and I and Fig. S5 F and L). Further-
more, coinjection of Mo-Meis2 with Mo-miR-204 (Fig. S2 M–O,
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Fig. S5A, and Table S2) or that of miR-204 with the Meis2-
TPmiR-204 target protector (Fig. S2 S–U, Fig. S5C, and Table S2)
fully rescued the coloboma phenotype and the normal levels of
D-V markers and Pax6 expression (Fig. 3 J–L, P–R and Fig. S5G,
I, M, and O).
Altogether, these data demonstrate that miR-204–mediated
control of the Meis2/Pax6 pathway contributes to D-V patterning
of the optic cup. Moreover, our ﬁndings reveal a previously
unidentiﬁed role for Meis2 in this morphogenetic event.
Discussion
MiRNAs appear to function as “master regulators” of key mo-
lecular pathways through their ability to ﬁne-tune gene dose (25);
consequently, they have basic roles in vertebrate organogenesis
and pathogenesis. The general importance of this class of mole-
cule in eye development is supported by effects observed in mice
after genetic inactivation of Dicer, a key enzyme of miRNA bio-
genesis (26). However, there is little information available on
individual miRNAs that contribute to the correct development
and function of the eye. Examples exist with miR-24a, miR-124,
and miR-26a for the regulation of apoptotic pathways, retino-
genesis, and circadian rhythms of mRNAs in the retina, re-
spectively (27–29). Here, we showed that a single miRNA can
regulate multiple aspects of eye development. Indeed, miR-204 is
required for lens differentiation, optic cup development, and
optic ﬁssure closure.
Starting from in silico predictions and using a variety of in vitro
and in vivo experimental approaches, we have shown thatMeis2 is
a bona ﬁde target of miR-204 activity. Our data also show that the
speciﬁc miR-204–mediated regulation of Meis2 modulates the
function of the Pax6 transcriptional network. These data indicate
that miR-204 is an essential component of the Meis2/Pax6 mo-
lecular pathway, and hence is an important element of the mo-
lecular network that regulates eye development in vertebrates
(Fig. 4). This regulatory cascade is strongly supported by a number
of observations. Meis2 directly activates Pax6 expression during
lens and retina development in the zebraﬁsh, chick, and mouse
(16, 19, 30). In medaka ﬁsh embryos, expression levels of olMeis2
and, concomitantly, those of olPax6 and its downstream targets
are up-regulated on miR-204 knock-down or inhibition of the
miR-204 interaction with its speciﬁc target site in the Meis2 3′-
UTR. Furthermore, the phenotypic alterations observed in miR-
204 morphants strongly resembled those reported for Meis2 or
Pax6 gain-of-function models (4, 16, 19, 30), which include ab-
errant lens differentiation and microphthalmia. Conversely, miR-
204 over-expression led to a signiﬁcant down-regulation of Meis2
activity, with phenotypic consequences similar to those observed
after Meis2 loss-of-function, in which a reduction of Pax6 gene
dose was also observed (16, 19, 30). Finally, concomitant knock-
down of olMeis2 andmiR-204 and protection of the olMeis2 target
site in miR-204–overexpressing embryos, signiﬁcantly rescued
expression of olPax6, olSox2, olProx1, and olα-ACrystallin in the
lens, which is consistent with a pathway in which miR-204 controls
lens differentiation through regulation of olMeis2 levels (Fig. 4).
During lens development, the progeny of epithelial cells mi-
grate into the transitional zone and elongate and differentiate into
lens ﬁber cells (18, 31). Timely differentiation and correct mi-
gration of lens ﬁbers are crucial for continuous addition of ﬁber
mass and formation of a correctly organized lens. The miR-204–
mediated control of olMeis2 appears to modulate gene expression
programs that control these events because its over-expression or
inactivation produces signiﬁcant changes in the expression of lens
differentiation markers. miR-204 also appears to control lens
morphogenesis, because lens epithelial cells were abnormally
positioned in Mo-204 morphants. However, this miR-204 activity
is very likely to be Meis2-independent, because protection of
Meis2 mRNA did not alter epithelial and lens ﬁber cell organi-
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Fig. 3. miR-204 is required for establishment of D-V polarity of the optic
cup. Frontal vibratome sections of control (A–C), Mo-miR-204 (D–F), miR-204
(G–I), Mo-Meis2/Mo-miR-204 (J–L), Meis2-TPmiR-204 (M–O), and Meis2-
TPmiR-204/miR-204 (P–R)–injected embryos processed for whole-mount RNA
ISH with probes speciﬁc for olPax6 (A, D, G, J,M, and P), olVax2 (B, E, H, K, N,
and Q), and olTbx5 (C, F, I, L, O, and R). olPax6 is up-regulated and ectopically
expressed in ventral retina of morphant embryos (D and M, asterisk). Ex-
pression of ventral gene olVax2 is reduced, whereas that of dorsal marker
olTbx5 is expanded ventrally in morphant embryos (E, F, N, and O) when
compared with control embryos (B and C). miR-204–overexpressing embryos
show reciprocal alterations in Pax6 and D-V marker expression (G–I). Defects
in D-V optic cup polarity are completely rescued by coinjection of Mo-miR-
204 with Mo-Meis2 (J–L) and Meis2-TPmiR-204 with miR-204 (P–R). (Scale
bars: 20 μm.)
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zation. Thus, miR-204 might ensure correct control of lens mor-
phogenesis by targeting other genes involved (e.g., in the control
of cell polarity, cell-cell signaling, tissue polarity, or cell migra-
tion). This last possibility is particularly attractive, because cells
with elevated miR-204 levels are highly mobile and have invasive
properties (32, 33).
The miR-204 contributed to other aspects of eye morphogen-
esis, as expected by its speciﬁc distribution in ocular tissues other
than the lens. The requirement for miR-204 in establishment of
D-V polarity in the optic cup and in optic ﬁssure closure can also
be explained by its control of Meis2 expression. Indeed, the
defects in D-V polarity and optic ﬁssure closure in the miR-204
and Meis2-TPmiR-204 morphants were rescued by coinjection
with Mo-Meis2 or miR-204, respectively. This is an as yet un-
reported aspect of Meis2 function that is probably mediated by
the observed ectopic ventral expression of Pax6, the overexpres-
sion of which correlates with signiﬁcant down-regulation of ven-
tral determinant genes, which leads to the formation of optic ﬁs-
sure coloboma (22, 23). However, the relatively low frequency of
optic ﬁssure defects in miR-204 morphants suggests that miR-204
might not serve as an “on-off” switch for the genetic program re-
quired for correct optic ﬁssure closure.
In miR-204 morphants, eye formation was initiated and pro-
gressed normally up to the optic cup stage; thereafter, it did not
advance correctly, leading to microphthalmia. This phenotype
might be a consequence of alterations in apoptosis and/or cell
proliferation, because previous studies have shown that members
of the Meis gene family can directly regulate these events. How-
ever, we found that the concomitant knock-down of Meis2 and
miR-204 was insufﬁcient to restore normal eye size (Fig. S2),
possibly becauseMo-Meis2 reduces the levels ofMeis2 expression
well below normal levels. Indeed, a microphthalmic phenotype
has been reported for loss-of-function Meis mutants in the chick
and zebraﬁsh (19, 29). Alternatively, the miR-204–mediated
regulation of eye size involves other, as yet unidentiﬁed, tran-
scriptional pathways.
Although miRNAs have the potential to regulate the expression
of hundreds of genes, we have shown that the speciﬁc miR-204-
Meis2 interaction has multiple consequences in eye development.
Of note, this action is mediated by a single miR-204 target site
within the 3′-UTR of the Meis2 gene, as demonstrated by the
speciﬁc target protector assay. Previous reports have proposed that
the presence ofmultiple target sites for the samemiRNAwithin the
3′-UTR of a given mRNA is a strong indication of the “strength”
and biological relevance of these interactions (34). However, in
agreement with our data, it has also been reported that point
mutations in a single miRNA recognition site have a pathogenetic
role in human genetic diseases (35). Thus, the mode of action of
miRNAs and their relevance in the control of basic biological
processes may be more complex than initially envisaged.
In conclusion, we have begun to unravel the function of miR-
204 during eye development, and we have demonstrated that this
is largely mediated byMeis2 targeting. As shown by our data, miR-
204 may have additional target genes in the eye. It will be of the
utmost importance to identify these and to determine whether
alterations in miR-204 expression contribute to the pathogenesis
of eye malformations in humans.
Materials and Methods
Medaka Stocks. Samples of the Cab strain of WT medaka ﬁsh were kept and
staged as described (36).
Computational Analysis. Prediction of miRNA targets was performed using
the Host gene Opposite Correlated TARgets (HOCTAR) tool (http://hoctar.
tigem.it) (15).
Mo and miR-204 Duplex Injections. Mos (Gene Tools, LLC) were designed and
injected into fertilized one-cell embryos, as detailed in Table S1. The speci-
ﬁcity and inhibitory efﬁciency of each Mo were determined as described
(14). Optimal Mo concentrations (Tables S1 and S2) were determined on the
basis of morphological criteria. miRIDIAN (Dharmacon) miRNA Mimics for
miR-204 were injected at a ﬁnal concentration of 4 μM. Embryos injected
with mm-Mo-miR-204 were used as controls.
Whole-Mount ISH.Whole-mount RNA ISHwas performed, photographed, and
sectioned as described (37). Digoxigenin-labeled antisense and sense ribop-
robes for olMeis2, olPax6, olα-ACrystallin, olSox2, olProx1, olBmp4, olTbx5.2,
olVax2, and olPax2 were used. The miRCURY detection miR-204 probe
(Exiqon) was used according to Karali et al. (11).
Western Blotting. Immunoblotting was performed as described (38), with
a rabbit polyclonal antibody against Meis2 (1:1,000) or an anti-β-tubulin
monoclonal antibody (1:1,000; Sigma).
Immunolabeling. Medaka embryos were cryostat-sectioned, and immuno-
chemistry was performed as described (39) using an anti-phospho-histone H3
monoclonal antibody (1:100; Cell Signaling Technology) and an anti-Meis2
rabbit polyclonal antiserum. Alexa-488–conjugated goat anti-rabbit or anti-
mouse (1:1,000; Invitrogen) IgGs were used as secondary antibodies. Alter-
natively, a peroxidase-conjugated anti-rabbit antibody (1:200; Vector Lab-
oratories) was used, followed by diaminobenzidine staining, as described
previously (40).
Cell Transfection, qRT-PCR, and Luc Assays. The H36CE human lens epithelial
cell line was grown as described (41). Cell transfections and qRT-PCR ex-
periments were performed as described (15). Cells were transfected with
either 50 nM miRIDIAN miRNA Mimics or 80 nM miRIDIAN miRNA Inhibitor
(Dharmacon). Plasmids containing the 3′-UTR of the humanMEIS2 gene and
psiUx plasmid constructs containing the hsa-premiR-204 sequence were used
in Luc assays, as described previously (15). Each assay was performed in
duplicate, and all the results are shown as means ± SD of at least three in-
dependent assays. The primer sequences used to amplify each transcript are
shown in Table S1.
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